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 1.0 INTRODUCTION 
 
Infectious diseases are caused by pathogens, which is clinically evident disease 
resulting from the presence of pathogenic microbial agents, including pathogenic viruses, 
pathogenic bacteria, fungi, protozoa, multicellular parasites, and uncharacteristic proteins 
known as prions. Infectious disease results from the interplay between those few pathogens 
and the defenses of the hosts they infect. The bacterial infections which contribute most to 
human disease are also those in which emerging and microbial resistance is most evident: 
diarrhoeal diseases, respiratory tract infections, meningitis, sexually transmitted infections, 
and hospital-acquired infections. Some important examples include penicillin-resistant 
Streptococcus pneumoniae, vancomycin-resistant enterococci, methicillin-resistant Sta-
phylococcus aureus, multi-resistant salmonellae, and multi-resistant Mycobacterium 
tuberculosis. The development of resistance to drugs commonly used to treat malaria is of 
particular concern, as is the emerging resistance to anti-HIV drugs. 
In recent years, an increase in the number of people in the world having health 
problems caused by various cancers, drug-resistant bacteria, parasitic protozoans, and fungi 
is a cause for alarm (Strobel and Gary, 2003). Antimicrobial agents are among the most 
valuable therapeutic agents in modern healthcare. Since their discovery during the 20th 
century, antimicrobial agents (antibiotics and related medicinal drugs) have substantially 
reduced the threat posed by infectious diseases. These gains are now seriously jeopardized 
by another recent development: the emergence and spread of microbes that are resistant to 
cheap and effective first-choice, or "first-line" drugs. Over the years, antimicrobials have 
saved the lives and eased the suffering of millions of people. By helping to bring many 
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serious infectious diseases under control, these drugs have also contributed to the major 
gains in life expectancy experienced during the latter part of the last century. 
 
There are four common reactive oxygen species (ROS) in biological systems that 
are free radicals: superoxide anion (O2
-
), hydrogen peroxide (H2O2), hydroxyl radical (OH
-
) 
and singlet oxygen (
1
O2). In addition, peroxynitrite (ONOO
-
) and nitric oxide (NO) and 
other reactive nitrogen species (RNS) are called free radicals. Free radicals can be 
generated via a number of mechanisms, including normal physiological processes and 
processes resulting from external factors. For example, singlet oxygen is generated by 
photosensitization reactions wherein a molecule absorbs light of a given wavelength, 
exciting the molecule (Stanner et al., 2004; Willcox et al., 2004).  
 
 There are increasing evidences indicating that reactive oxygen species (ROS) and 
free radical-meditated reactions are involved in degenerative or pathological events such as 
cancer, cardiovascular disease, atherosclerosis, coronary heart ailment, Alzheimer‘s disease 
and diabetes. The oxidative damage to DNA, proteins and other cellular determinants 
seems inevitable when the concentration of ROS exceed tolerability of cells. Antioxidant 
could attenuate this oxidative damage of a tissue indirectly by increasing cells‘ natural 
defenses and or directly by scavenging the free radical species (Schinella et al., 2002). 
 
Over the last decade, considerable experimental evidence has confirmed the 
importance for health of following a diet rich in antioxidants, which can protect the 
organism against the damage caused by these radicals. Some of these antioxidants are well 
known, such as vitamins (particularly vitamins E and C) and carotenoids, including β-
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carotene. Furthermore, some polysaccharides have been disclosed to be potent antioxidants 
(Hou et al., 2005; Kim et al., 2003).  
 
Cancer is a group of diseases characterized by uncontrolled growth and spread of 
abnormal cells. If the spread is not controlled, it can result in death. Cancer begins when 
cells in a part of the body start to grow out of control. There are many kinds of cancer, but 
they all start because of out-of-control growth of abnormal cells (Jeanne and Carmen, 
2009). Cancer is caused by both external factors (tobacco, infectious organisms, chemicals, 
and radiation) and internal factors (inherited mutations, hormones, immune conditions, and 
mutations that occur from metabolism). These causal factors may act together or in 
sequence to initiate or promote carcinogenesis.  
 
Cancer is not just one disease but many diseases. There are more than 100 different 
types of cancer. Most cancers are named for the organ or type of cell in which they start. 
For example, cancer that begins in the colon is called colon cancer and cancer that begins in 
basal cells of the skin is called basal cell carcinoma. Cancer types can be grouped into 
broader categories which include: Carcinoma as a cancer that begins in the skin or in 
tissues that line or cover internal organs; Sarcoma as a cancer that begins in bone, cartilage, 
fat, muscle, blood vessels, or other connective or supportive tissue; and Leukemia as a 
cancer that starts in blood-forming tissue such as the bone marrow and causes large 
numbers of abnormal blood cells to be produced and enter the blood (Lim, 2001).  
 
Cancer is treated with surgery, radiation, chemotherapy, hormone therapy, 
biological therapy, and targeted therapy. Choice of cancer treatment is influenced by 
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several factors, including the specific characteristics of cancer; overall condition; and 
whether the goal of treatment is to cure cancer, keep cancer from spreading, or to relieve 
the symptoms caused by cancer.   
 
A growing number of fungi are the sources of novel and potentially life-saving 
bioactive secondary metabolites. Fungi produce an enormous array of secondary 
metabolites, some of which are important in industry.  Fungi are well known for their vast 
diversity of secondary metabolites including antibiotics, amino acids, fuel (ethanol, biogas), 
single cell protein, biopesticeds, mycoherbicides, preservatives, vitamins, organic acid etc.  
Investigating the metabolites of fungi increased the chance of founding novel compounds.   
  
In fungi, besides enzymes of biotechnological application and other products 
including biocontrol agents, the metabolites of pharmaceutical application are of great 
interest for counteracting common ailments. Bioactive fungi metabolites are believed to 
have capability to help in revitalization of immune system against a large number of 
pathogenic and non-pathogenic diseases. Investigating the metabolites of fungi increased 
the chance of founding novel compounds. Medicinal mushroom have widely used as tonics 
food and herb remedies since ancient times, are rich with medicinal properties and have  
been increasingly recognized through modern scientific research to have promising 
immunodulatory activities (Wasser, 2002). Mushrooms are considered to be a good source 
of proteins. Extracts from medicinal mushrooms have been used in traditional medication.  
 
 Penicilliopsis is a genus in the family Trichocomaceae phylum Ascomycota. It is 
teleomorphic fungus and classified under the Ascomycetes. The thallus (mycelium) 
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typically consists of a highly branched network of multinucleate, septate, and yellow in 
colour. It is easy to culture in the laboratory and has a fast growth within 48 hours.  
 
To the best of our knowledge, the biological properties from Penicilliopsis sp. have 
not yet been reported.  Therefore, the present study was carried out to evaluate the 
biological activities such as antioxidant, antimicrobial, cytotoxicity and anti human 
papillomavirus in Penicilliopsis sp. (KUM60280) collected from Malaysian forest. 
 
The specific objectives of this study were: 
1. To obtain mycelial biomass of Penicilliopsis sp. by liquid fermentation. 
2. To extract bioactive compounds using methanol and dichloromethane. 
3. To determine the antimicrobial activity of crude extracts of   Penicilliopsis sp.   
4. To evaluate the antioxidant property of Penicilliopsis sp. extracts based on its 
ability to scavenge free radicals and reducing power and to determine the total 
phenolic content of the extracts using the Folin-Ciocalteau method. 
5. To analyze the cytotoxic potentials of methanol and dichloromethane crude 
exrtracts of Penicilliopsis sp. against cancer derived cell lines and normal cell lines. 
6. To evaluate crude extracts of Penicillliopsis sp. for the the anti-human 
papillomavirus 16 E6 activity. 
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2.0 LITERATURE REVIEW 
 
2.1 Characterization of Fungi 
Fungi are unique group of organisms, different from all others in their behavior and 
cellular organization. Fungi have been traditionally used to produce a variety of important 
substances for the pharmaceutical and food industries (Marley et al., 2004). Hence, primary 
and secondary metabolites, such as peptides, enzymes, organic acids and antibiotics 
produced by filamentous fungi are used for these purposes (Benette, 1998: Demain, 2000). 
Fungi are potential sources of secondary metabolites with biological activities.  Fungi have 
been recognized for their utilization in developing and testing many kinds of hypotheses, as 
a model system in biology, as a creature of pure beauty. The fungi constitute a very large 
group of organisms found in virtually every ecological niche.   
 
2.2 Penicilliopsis species 
 
The genus Penicilliopsis was first described by Solms-Laubach (1886) on seeds of 
Diospyros macrophylla collected in the Botanical Garden of Bogor, Indonesia. It is the 
teleomorphic fungus, but was subsequently misapplied to various synnematous fungi. The 
detailed description clearly depicts an ascomycete with a phialidic anamorph.  
Penicilliopsis is a genus in the family Trichocomaceae phylum Ascomycota. The 
Penicilliopsis is classified under the Ascomycetes. Given conspicuous synnemata produced 
by these species and their common occurrence in tropical rain forests, it is surprisingly that 
the group has not been critically reexamined in the past fifty years. This fungus which 
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preferably lives on ground or rock is yellow in colour usually in branching form. However 
no investigation has been done to study the biological properties of this fungus. 
Penicilliopsis have been found fairly spread in the tropics especially from Brazil, Taiwan, 
Ivory Coast, Papua New Guinea, Indonesia, Singapore and Malaysia (Huei & Yu, 2001).   
 
2.3 The Production of Secondary Metabolites by Fungi 
 Four groups of organisms are particularly good producers of secondary metabolites: 
plants, fungi, lichens, and actinomycetes, whereas yeasts, protozoa, and animals are less 
efficient producers (Frisvad et al., 2007). Fungi are a major source of bioactive secondary 
metabolites which are of major importance in ecological chemical interactions (Camazine 
et al. 1983; Sterner, 1995). They can also play a major role in the combat of many human 
and animal diseases (Müller, 2001; Vicente et al. 2003; Peláez, 2005).  
A fungal secondary metabolite is a chemical compound produced by a limited 
number of species in a genus, an order, or even a phylum and has a differentiation power.  
A profile of secondary metabolites compiled by the mycologyst is based on fungal extracts 
(Frisvad et al., 2007).  A classic example is penicillin produced commercially from a strain 
of Penicillium chrysogenum but originally discovered as a metabolite of P. notatum. Its 
discovery literally changed the course of medicine and has saved millions of lives. Other 
antibiotics produced by fungi are cephalosporins and griseofulvin (from fungus P. 
griseofulvum) to threat dermatophyte infections of humans, and fusidic acid (from various 
fungi) used to control Staphylococci than have become resistant to penicillin. Table 2.1 
showed several fungal metabolites having practical applications in horticulture, medicine or 
research.  
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The pectic enzymes of fungi are used to clarify fruit juices. Whereas, fungal 
amylase is used to convert starch to maltose during bread-making, and fungal rennet is used 
to coagulate milk for cheese making. The wood-rotting fungus Phanaerochaete 
chrysosporium important in degrading lignin, has the potential to be developed for 
delignification of agricultural wastes and by-products of the wood-pulping industry so that 
the cellulose can be used as a cheap substrate for production of fuel alcohol by yeast 
(Deacon, 2000). Genetic engineering of fungi, particularly Saccharomyces cerevisiae, has 
been developed to the stage where the cells can be used as factories to produce 
pharmaceutical products, by the introduction of foreign (heterologous) genes.   
Table 2.1 Fungal secondary metabolites produced commercially for pharmaceutical, 
agricultural and research uses (Deacon, 2000) 
Usage Product Fungal source Application 
Medicine Penicillin 
Cephalosporin 
Griseofulvin 
Fusidin 
Cyclosporin 
Ergot alkaloids 
Penicillium chrysogenum 
Chephalosporium acremonium 
P. griseofulvum 
Fusidium coccineum 
Trichoderma polysporum 
Claviceps purpurea   
         Antibacterial 
        Antibacterial 
       Antifungal 
       Antibacterial 
     Immunosupressant 
   Induces labour, migraine 
treatment 
Agriculture Zearalenone Gibberella zeae 
G. fujikoroi 
 Growth promoter for cattle 
     Plant hormones 
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It is not unusual that different fungal species have one or more secondary 
metabolites in common. Cytochalasin D is one such metabolite. It is produced by several 
fungal species as different as Coriolus vernicipes (a basidiomycete), Zygosporium masonii 
(a zygomycete), and Metarrhizium anisopliae, Engleromyces goetzii, and Hypoxylon 
terricola (ascomycetes) (Cole & Schweikert, 2003). Many secondary metabolites are 
produced widely by different fungi (Cole & Schweikert 2003; Vicente et al. 2003). All 
species in Penicillium subgenus Penicillium series Verrucosa produce arabenoic acid (syn. 
verrucolone). All species in Aspergillus section Circumdati produce penicillic acid, except 
the phylogenetically outlying species A. elegans and A. steynii (Frisvad et al. 2004b). 
Whereas all species in Aspergillus section Flavi, except the phylogenetically outlying A. 
avenaceus, produce kojic acid (Frisvad et al., 2007). Emodin, an anthraquinone produced 
by fungi as different as Cortinarius sanguineus (basidiomycete) and Penicillium islandicum 
(ascomycete) (Turner, 1971), is also produce by rhubarbs (Rheum rhaponticum).  
 Technologies based on the degerative or synthetic activities of the fungi have 
become an integral part of the human society. Current commercial product of fungi include 
amino acids, antibiotics, fuel (ethanol, biogas), biopesticides, mycoherbicides, bread, 
cheese, fermented food, food(mushroom, etc), single cell protein, flavours, food colourants, 
preservatives, soy sauce, vitamins, organic acid and mycelial paper. Bioremediation, 
ensilage, biotransformation and many such processes involved the utilization of fungi.  In 
the emerging ‗age of biotechnology‘, the fungi are expected to provide a wider range of 
useful products and processes for human welfare under the banner of what is called ‗fungal 
biotechnology ‗(Moss, 1990).  
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2.4 Antimicrobial Activity in Fungus 
 
Antimicrobial is a general term given to substances including medicines that kill or 
slow the growth of microbes. Increasing use of antimicrobials in humans, animals, and 
agriculture has resulted in many microbes developing resistance to these powerful drugs. 
Many infectious diseases are increasingly difficult to treat because of antimicrobial-
resistant organisms, including HIV infection, staphylococcal infection, tuberculosis, 
influenza, gonorrhea, candida infection, and malaria. Antimicrobial diseases are now more 
frequent than during the half of the century, being still difficult to diagnose clinically (Jian 
et al., 2007). Several antimicrobials have been developed over the years to control these 
microorganisms. There is a need to search for new antimicrobial agents because infectious 
disease is still a global problem because of the development and spread of drug-resistant 
pathogens (Espinel et al., 2001).  
 
Research on biologically active compounds from fungus has always been of great 
interest for scientists looking for new sources of useful drugs against infectious diseases. 
Nowadays, bacterial resistance and its rapid increase is a major concern of global public 
health. Resistance development is an even bigger problem since the baacterial resistance is 
often not restricted to the specific antibiotic prescribed, but generally extends to other 
compounds of the same class. Alarmingly, methicillin-resistant Staphylococcus aureus 
(MRSA), methicillin-resistant Staphylococcus epidermidis, vancomycin-resistant 
enterococci (VRE), amphicillin-resistant Escherichia coli and even vancomycin-resistant 
Staphylococcus aureus (VRSA) have emerged as common nosocomial infections (Gou et 
al., 2005). Although antimicrobial resistance was recognized soon                                                                               
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after the deployment of sulfanomides and penicillin, it now appears that the emergence of 
antibiotic-resistant bacteria is inevitable to most drugs. In the last two decades, the 
incidence of human fungal infections has increased dramatically, in parallel with the wide 
spread of incurable infectious diseases associated with antibiotic-resistant bacteria (Woong 
et al, 2006). As a consequences, new efforts to develop new antimicrobial agents are highly 
needed (Özlem et al., 2007).  
 
To overcome the alarming problem of microbial resistance to antibiotics, the 
discovery of novel active compounds against new targets is a matter of urgency. Bacterial 
resistance to existing drugs is a constantly growing problem that, combined with a decline 
in the development of new antibiotics, presents a significant threat to human health 
(Christian et al., 2007). Thus, microbes have the ability to release compounds that inhibit 
the growth of other microorganisms which depends on genetic factors and environmental 
condition. A number of 10–50 amino acid residues long, very often cationic peptides, have 
been identified from both vertebrate and invertebrate sources. They act in a variety of ways 
against many Gram-negative and Gram-positive organisms. The majority of experiments 
investigating their mode of action have focused primarily on the interaction of cationic 
peptides with model membrane systems.  
 
In the global problem of bacterial resistance to the commonly used antibiotics these 
properties make cationic peptides valuable candidates as future therapeutic agents to 
combat bacterial, viral, and fungal infections (Karaman et al., 2003). Recently, the use of 
fungal products in medicinal treatment and in health foods has become very popular since 
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1990s and more so since the outbreak of the Severe Acute Respitory Syndrome (SARS) in 
China in 2003 (Dong and Yao, 2007).  
 
In September 2001, World Health Organization (WHO) launched the first global 
strategy for combating the serious problems caused by the emergence and spread of 
antimicrobial resistance. Known as the WHO Global Strategy for Containment of 
Antimicrobial Resistance, the strategy recognizes that antimicrobial resistance is a global 
problem that must be addressed in all countries. No single nation, however effective it is at 
containing resistance within its borders, can protect itself from the importation of resistant 
pathogens through travel and trade. Poor prescribing practices in any country now threaten 
to undermine the potency of vital antimicrobials everywhere. Several antimicrobials have 
been developed over the years to control these microorganisms (Mencher and Wang, 2007).  
 
A large number of fungal extracts and or extracellular products have been found to 
have antimicrobial activity, mainly the filamentous fungus Penicillum sp. Since the 
discovery of penicillin, the mycromycetes have been famous as producers of antibiotics and 
otheer ―secondary metabolites‖ with biological activity (Ana et al., 2006). Kurobane et al. 
(1981) reported that Penicillium brefeldianum produce fulvic acid which possessed 
antiviral, antifungal, antioxidant and antibiotic activities. Maskey et al. (2003) isolated two 
active substances 8-O-methylaverufin and 1,8-Odimethylaverantin as new antifungal agents 
from Penicillium chrysogenum. Nam et al. (2000) found that compounds 8-
Omethylsclererotiorinamine isolated from Penicillium multicolor showed antimicrobial 
activity.  
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2.4. 1 Antimicrobial Susceptibility Testing 
 
Disc diffusion susceptibility is based on the inoculation of the surface of an agar 
plate with a suspension of the test organism followed by application of a paper disc 
containing a defined quantity of antimicrobial agent. Disc diffusion method is among the 
most widely adopted alternative approaches (Martin et al., 2001). The antimicrobial agent 
diffuses from the paper disc into the surrounding medium and a gradient of antimicrobial 
concentration is established around the disc with the highest concentration immediately 
adjacent to the disc and progressively lower concentrations as distance from the disc 
increases.  The interaction of the antimicrobial agents diffusing through the medium with 
the organism on the surface of the agar plate results in inhibition of bacterial growth for a 
variable distance around the paper disc. There is the relationship between the diameter zone 
of inhibition of bacterial growth around the disc and the MIC of the test organism for the 
particular antimicrobial agents.  In general terms, the lower the MIC for a particular 
antimicrobial agent, the larger the diameter of the zone of inhibition growth.  
 
A fundamental concept of in-vitro susceptibility testing is the measurement of 
minimum inhibitory concentration (MIC). The MIC is the lowest concentration of 
antimicrobial agent that presents visible growth of the microorganisms (Martin et al., 
2001). The MIC is measured by exposing the organism, under conditions that are otherwise 
suitable for growth, to a range of concentrations of the antimicrobial agent (usually in 
dilution series). After a period of incubation that is at least sufficient to allow visible 
growth in the absence of antimicrobial agents, the culture medium is inspected to identify 
the lowest concentration of antimicrobial agents at which no growth is visible.  
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Determination of MIC can be costly and time consuming and as a result a number of 
alternative approaches to antimicrobial susceptibility testing have been developed.   
 
2.5 Antioxidant Activity  
 
Oxidation and reduction reactions must occur in pairs (i.e., when one atom or 
molecule is oxidized, another is reduced to defend against the potentially damaging effects 
of free radicals). Highly reactive molecules can oxidize molecules (i.e., remove electrons 
from molecules) that were previously stable and may cause them to become unstable 
species, such as free radicals.  Free radicals are involved in the onset of many diseases such 
as cancer, rheumatoid arthritis, cirrcosis and arterioscelerosis as well as in degenerative 
process associated with ageing (Mariani et al. 2005).   
 
Free radicals are produced in normal cell metabolism.  A free radical is a chemical 
species with an unpaired electron that can be neutral, positively charged, or negatively 
charged.  Although a few stable free radicals are known, most are very reactive (Paul et. al., 
2006). In free radical chain reactions, the radical product of one reaction becomes the 
starting material for another, propagating free radical damage.  Metabolism is not the only 
source of free radicals.  Halliwell and Gutteridge (2003) acknowledged that exogenous 
chemical and endogenous metabolic processess in the human body or in the food system 
might produce highly reactive free radicals, especially oxygen derived radicals which are 
capable of oxidizing biomolecules, resulting in cell death and tissue damage. Most of 
organisms are well protected against free radical damage by oxidative enzymes such as 
superoxide dismutase (SOD) and catalase (CAT) or chemical compounds such as α-
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tocopherol, ascorbic acid, carotenoids, polyphenol compounds and glutathione (Niki et al., 
1994).  
 
Environmental pollutants are sources for free radicals including nitrogen dioxide, 
ozone, cigarette smoke, radiation, halogenated hydrocarbons, heavy metals, and certain 
pesticides (Katalinik et al., 2006). Alcohol consumption can induce oxidative reactions in 
the liver. Certain chemotherapeutic agents including doxorubicin, cyclophosphamide, 5-
fluorouracil, methotrexate, and vincristine can produce oxygen radicals at doses used in 
cancer patients. Increased physical activity can generate free radicals as the result of 
increased oxygen consumption during exercise.  
 
There are three steps to the free radical chain reaction: initiation, propagation, and 
termination (Paul et al., 2006).  In the initiation step, free radicals are formed from 
molecules that readily give up electrons, such as hydrogen peroxide. In the propagation 
steps, the chain-carrying radicals are alternately consumed and produced. In the termination 
steps, radicals are destroyed. Thus, without termination by an agent such as an antioxidant, 
a single free radical can damage numerous molecules. 
 
Antioxidants played an important role in lowering oxidative stresses caused by 
reactive oxygen species (ROS). ROS including superoxide anion radical, hydroxyl radical 
and hydrogen peroxide are generated under physiological and pathological stresses in 
human body (Nordberg and Arner, 2001). Some severe chronic diseases, such as arthritis, 
cancer, diabetes, cardiovascular diseases, inflammations and neurological disorders are 
related to the imbalance of ROS formation and their elimination (Halliwell, 1996). 
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Antioxidants protect against these complex diseases through scavenging free radicals and 
reducing hydrogen peroxide (Shahidi and Wanasundara, 1992). Despite the actions of 
antioxidant nutrients, oxidative damage occurs inevitably over time in most cells, and 
accumulation of this damage throughout life is believed to be a major contributing factor to 
aging and chronic diseases including cancer (Paul et. al, 2006). The balance between 
antioxidant and oxidation is believed to be critical in maintaining a healthy biological 
system (Judge et al., 2005; Katalinik, et al., 2006).  
 
 Recently, many reseachers have taken a great interest in fungi for their phenolic 
concentration and related total antioxidant potential (Mahfuz et al, 2007).  A wide study 
variety of fungi have produced novel antioxidants (Yang et al., 2002).  These include 
Penicillium roqufortii, Aspergillus candidus, Mortierella sp., Emericella falconensis and 
fungi of the genus Acremonium. Therefore, the identification and study of novel 
compounds characterized with antioxidant activity from fungal sources is an important 
strategy to improve human health condition and life quality.  
 
Wild edible mushrooms are conventionally used in many Asian countries in both 
food and medicine (Isildak et al, 2004; Türkekul, et al, 2004, Manzi et al, 1999, Sanmee et 
al., 2003). Mushrooms have also been reported as therapeutic food that is useful in 
preventing diseases such as hypertension, hypercholesterolemia and cancer.  These 
functional characteristics are mainly due to their chemical composition (Manzi et al, 2001).  
In most countries, there is a well established consumer acceptance for cultivated 
mushrooms (Agaricus bisporus, Pleorotus spp., Lentinus edodes, Vorveriella volvacea, 
Auricularia spp.).  Nevertheless, wild edible muhrooms are becoming more and more 
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important in our diet for their nutritional and pharmacological characteristics (Manzi et al., 
2001).  
 
2.5.1 Antioxidant Assays 
 
Several assays have been frequently used to estimate antioxidant capacities in fugus 
including 2,2- azinobis (3-ethyl-benzothiazoline-6-sulfonic acid) / (ABTS), (Miller,1997), 
2,2-diphenyl-1-picrylhydrazyl (DPPH) (Brand-Williams et al., 1995) ferric reducing 
antioxidant power (FRAP) (Benzie, 2003) and the oxygen radical absorption capacity 
(ORAC) (Ou et al., 2002).   
 
2.5.1.1 The 2,2-diphenyl-1-picrylhydrazyl (DPPH
.
) Assay  
 
The DPPH
. 
assay  is one of the method in antioxidant testing. The  DPPH
. 
is a stable 
free radical that can accept an electron or hydrogen radical converting into stable, 
diamagnetic molecule. The DPPH
. 
assay primarily evaluates proton radical scavenging 
activity. The 2,2-diphenyl-1-picrylhydrazyl, sometimes known as α,α-diphenyl-β-
picrylhydrazyl (DPPH
.
) (molecular formula=C18H12N5O6; molar mass 384.33 g/mol), is a 
free radical compound usually tested to determine the free radical scavenging ability of 
antioxidant polyphenols in environment, including in plants, food and baverages.  As this 
electron becomes paired off, the absorption decreases stoichiometrically with respect to the 
number of electron taken up. Such a change in absorbance produced in this reaction has 
been widely used to test the ability of several molecules to act as free radical scavengers 
(Dinis et. al., 1994). Singh and Rajini (2003) reported that scavenging DPPH
.
 by 
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antioxidant due to their hrydrogen-donating ability. The hydrogen atoms or electrons 
donating ability of the corresponding extracts and some pure compounds was measured 
from the bleaching of purple coloured methanol solution of DPPH
.
. The adequacy of the 
methodology was determined by a dose dependent curve and the absence of formulation 
interference in the detection of extracts antioxidant activity using DPPH
.
  assay.   
 
According to Brand-Williams et al. (1995), the DPPH
.
 technique is performed in a 
polar medium such as methanol at ambient temperature without any additional oxygen.  
The radical is stable because of the spare electron delocalised over the whole molecule that 
is responsible to changes in colour from deep violet colour to light yellow due to picryl 
group (Mau et al., 2001). The DPPH
.
 has a strong absorption band at 517 nm and 
paramagnetic because of its odd electron. However, it can accept an electron or hydrogen 
radical to become stable and diamagnetic.      
 
Besides studing the sample extracts, a standard or positive control such as ascorbic 
acids or Butylated hydroxyanisole (BHA) should be included. DPPH
. 
and L-ascorbic acid 
should be prepared daily and kept in a flask wrapped with aluminium foil to protect from 
light, and stored at 4
o
C in between measurement. L-ascorbic acid is an organic acid also 
known as Vitamin C that can be easily destroyed by light, heat and metal oxygen. It must 
be stored in the cold and dark and not in metal container.  
 
The reaction was monitored until it has reached a plateau and the reaction kinetics 
was plotted. Determination of percentage inhibition at steady state was done from the 
plotted graphs (Sanchez-Moreno et al., 1999). The values of percentage inhibition should 
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then be tranferred onto another graph for showing the percentage of inhibition as a function 
of antioxidant concentration. Mau et al (2001) stated that usage of the EC50 value has 
drawbacks in showing the results because the higher the antioxidant activity, the lower the 
value of EC50. The disadvantage of presenting the results in bar graph is bars with low EC50 
value are visually short in the graphs and mistakenly preceived as low efficiency. 
 
2.5.1.2  The Reducing Power Assay 
 
A simple, automated test measuring the ferric reducing ability of plasma, the FRAP 
assay, is presented as novel method for assessing ‗‗antioxidant power‘‘. Ferric to ferrous 
ion reduction at low pH causes a colored ferrous-tripyridyltriazine complex to form. A 
biological antioxidant has been defined as ‗‗any substance that, when present at low 
concentrations compared to those of an oxidisable substrate, significantly delays or 
prevents oxidation of that substrate‘‘ (Halliwell and Gutteridge, 1999). This definition is 
clear and covers every member of the antioxidant defense team. The method described 
measures the ferric reducing ability of plasma (FRAP). At low pH, when a ferric-
tripyridyltriazine (Fe III -TPTZ) complex is reduced to ferrous (Fe II) form, an intense blue 
color with an absorption maximum at 593 nm develops (Benzie, 2003; Liu et. al., 1982).  
 
The reaction is nonspecific, and any half-reaction which has a less-positive redox 
potential, under reaction conditions, than the Fe III /Fe II -TPTZ half-reaction will drive Fe 
III -TPTZ reduction. Test conditions favor reduction of the complex and, thereby, color 
development, provided that a reductant (antioxidant) is present. Ferrozine is a compound 
closely related to TPTZ, has been widely used with excess ascorbic acid, to measure iron. 
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In the FRAP assay, excess Fe III is used and the rate limiting factor of Fe II -TPTZ, and 
color formation is the reducing ability of the sample.  
 
2.5.2 Total Phenolic Contents in Fungal Metabolites 
 
 Phenolics are a source of natural antioxidants and closely associated with the 
aroma, acceptibility, taste, nutritional quality and stability of food by acting as colorants, 
flavourings and antioxidant.  Phenolic acids are thought to play a positive role in prevention 
of human diseases and food industry.  Phenolics are one of the major groups of non-
essential dietary components that have been assiociated with the inhibition of 
atherosclerosis and cancer (Williams and Iatropoulus, 1997).  The bioactivity phenolics 
may be related to their ability to chelate metals, inhibit lipoxygenase and scavange free 
radicals (Decker, 1997).   
 
The key role of phenolic compounds as scavangers of free radicals is emphasised in 
several reports (Komali et al., 1999; Moller et al, 1999).  The phenol are oxidized rapidly in 
solutions sufficiently alkaline to give appreciable concentration of the phenolate ions.  
Antiradical antioxidants act by donating hydrogren atoms to lipid radicals. Imeh and 
Kokhar (2002) reported that phenolics as antioxidants are important in food and biological 
systems because they are preferentially oxidized, thus sparing nutrients, cells and tissues.   
 
Mushroom accumulates a variety of secondary metabolites, including phenolic 
compounds, polyketides, terpenes and steroids. Phenolic compounds were found to have 
antioxidant activity in the inhibition of Low Density Lipid, LDL oxidation (Teissedre & 
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Landrault, 2000).  Some edible mushrooms, which are widely consumed in Asian culture, 
have currently been found to posses antioxidant activity which is well correlated with their 
total phenolic content.   
 
The Follin-Ciocalteau method is often used to measure total phenolic compound.  
The total phenolic contents of the extracts samples are expressed in miligrams per saving of 
gallic acid equivalent (GAE). Gallic acid (Formula Molecule = C7H6O5; Formula Weight = 
170.12) is preferable reference because of its stability, solubility, low price and purity.  
Singleton and Rossi (1965) stated that the active ingredient in the Follin-Ciocalteau reagent 
is yellow acidic solution with complex ion formed from phosphomolybdic and 
phosphotungstic acids. The colour formation is due to the reactions of monohydric phenols 
polyphenols, flavonoids, tannins and other readily oxidized subtances such as ascorbic 
acids. Such reagent oxidizes phenolates and the oxidation states of the acidsare reduced 
from +6 to a mixture of +6 and +5.  A blue molybdenum tungsten omles was formed.  
Incubation is necessary for colour development because time is required for a complete 
reaction. Na2CO3 is added because phenol oxidizes rapidly in alkaline solutions. The 
carbonate should be added exactly three minutes after the Follin-Ciocalteau reagent was 
added. However, it is important to mix the sample and the Follin-Ciocalteu reagent under 
dilute conditions before addition of the carbonate.  Na2CO3 (Formula Weight =105.99) is 
preferred over NaCN or NaOH because with NaCN, the blue colour fades instantly whereas 
NaOH provides a precipitation problem. The reference standard can be any convenience, 
known and reactive phenolic compound. 
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The limitation of the Folin-Ciocalteau method is the reaction is based on reduction–
oxidation activities. Thus, the assay would not be specific to just phenolics but to any other 
substance that could be oxidised by the Follin reagent. Frankel et al.(1995) reported that the 
total phenolics determined in the Follin-Ciocalteau method do not give the abselute 
measurement of the amount of phenolics materials. Various phenolics compounds respond 
differently to this assay. Even though there is no specific extraction method for all 
phenolics present in a sample, extraction method, nature of the phenolic compound, 
presence of interfering substances, sample size, storage conditions and time and standard 
selections influence the analysis of the phenolics compounds. The extract usually contains a 
mixture of phenolic compounds that are soluble in the chosen solvent.   
 
 
2.6 Cytotoxicity of Fungal Metabolites 
 
Fungal growth occurs under favorable environmental conditions and it is associated 
with the production of secondary metabolites, many of which can be hazardous to 
vertebrates (animals and humans) (Kokkonen et al., 2005). Toxin of fungal origin is known 
as mycotoxins. The conditions which promote mycotoxin production are usually more 
restricted than those for mold growth. Mycotoxins are toxic secondary metabolites 
produced by about 200 identified filamentous fungi such as Fusarium, Aspergillus and 
Penicillium species, growing under a wide range of climatic conditions on agricultural 
commodities (grains, spices, fruits, coffee, nut) in the field and during storage (Krogh, 
1987; Miller and Trenholm 1997). Their amount in food, beverages and feed has been 
recognised as potential threat to human and animal health, either caused by direct 
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contamination of plant materials or products thereof, or by ―carry over‖ of mycotoxins and 
their metabolites into animal tissues, milk and eggs after intake of contaminated feed. 
 
Evidence of mycotoxicoses can be traced back to ancient times and the middle ages 
(ergotism). However, it was not before 1960, that mycotoxins were identified as potential 
health hazard when 100 000 turkeys died from an acute necrosis of the liver after 
consuming groundnuts infected by Aspergillus flavus and contaminated by aflatoxins (X-
disease) (Peter & Bernhard,  2006). Today, aflatoxins, trichothecenes, ochratoxin A (OTA), 
zearalenone (ZEN), fumonisins, moniliformin and patulin receive by far the greatest 
attention due to their frequent occurrence and their severe effects on animal and human 
health (Peter & Bernhard,  2006).  Aflatoxins are secondary metabolites of the molds 
Aspergillus flavus and Aspergillus parasiticus. They are potent carcinogens, teratogens, 
genotoxics, nephrotoxic, neurotoxic, immunosuppressive and mutagens and pose severe 
hazards to animal and human health (Stavroula et al., 2006).  
 
 Less critical compounds and chronic intake of small amounts of mycotoxins may 
reduce feed intake and weight gain in animals and cause diarrhoea in humans (Peter & 
Bernhard, 2006). Several endemic diseases in Asia, Africa and Europe are now correlated 
to acute mycotoxin intoxication, such as Kwarshiorkor and Reye‘s syndrome (damage to 
liver and kidney caused by (aflatoxins) and Balkan Endemic Nephropathy (tumors of the 
upper urinary tract caused by ochratoxin A).  Ochratoxin A (OTA) is a toxic metabolite 
produced by the molds Aspergillus ochraceus and Penicillium verrucosum and related 
species (Seudomore & Patel, 2000). The International Agency for Research on Cancer 
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(IARC) has classified OTA as a ‗‗possible human carcinogen‘‘ (Group 2B) (International 
Agency for Research on Cancer (IARC), 1995).  
 
Factors contributing to their presence or production in food and feed include 
storage, environmental and ecological conditions, as temperature, relative humidity, the 
substrate and the use of fungicides, though the interrelations between all these factors are 
not yet well understood and toxin production cannot reasonably be predicted.  Surveillance 
studies showed that mycotoxin contamination is a world-wide problem (Final report 
SCOOP: Placenta et al., 1999).  It is estimated that 25% of the world‘s crop production and 
20% of crop production within the European Union may be contaminated with mycotoxins 
(Peter and Bernhard, 2006). ZEN is non-steroidal estrogenic mycotoxin in corn, cereals and 
animal feeding (Placinta et al., 1999; Muller et al., 1998; Seudamore and Patel, 2000). 
 
Medicinal fungi have been widely used as tonic foods and herbs remedies since 
ancient times and their medicinal properties have been increasingly recognized through 
modern scientific research (Jian et al., 2007). In the search of alternative medicines and 
natural therapeutics for cancer therapy, medicinal fungus is the most promising targets 
because of their notable immunomodulatory activities (Wasser, 2002). Because of the 
natural scarcity of most medicinal fungi, the cultivation of mycelia, fruiting bodies and the 
whole fungi by solid and submerged fermentation has become the main source of fungal 
supply (Smith et al, 2002; Chang and Miles, 2004). Novel anti-cancer drugs are also 
required due to the high worldwide mortality (Pisani, et al., 1999). 
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2.6.1 In vitro Cytotoxicity Assay 
 
In vitro assays are important and useful tools in toxicity assessment of various 
classes of environmental contaminants including fungal metabolites not only because they 
significantly reduce evaluation time, but also because they provide information about the 
mode of action of the toxicant (Francesca et al., 2004). In the search for new anticancer 
drugs, the most common screening methods employ cytotoxicity tests against panel of 
cancer cell lines. Depending on the design, in vitro cytotoxicity experiments could provide 
information of compounds with potential basal toxicity (intrinsic activity of chemicals that 
is common to all cell types), metabolism-mediated toxicity (chemicals require metabolic 
activation) and selective toxicity (chemicals interfere with cell-specific functions) (Robert 
et al., 2007).  
 
Anticancer drugs are designed to kill cells and such activity should be selective 
towards tumor cells.  Therefore, it seems reasonable to utilize at the primary stage, in vitro 
assays to select the least toxic compounds among the most active ones (Joanna, et al.,, 
2005). This information is crucial at the early stage of development of pharmaceutical 
drugs or crop protection chemicals.  
 
In order to screen of large number of lead compounds in a relatively short period of 
time, cytotoxicity is routinely evaluated using permanent cells lines in 96-well plate format. 
In vitro tests are useful and necessary for screening purposes to define dose and time-
dependent cytotoxicity, considered primarily as the potential of a compound to induce cell 
death, in different cell types (Eisbrand et al., 2002). In the exploration of anticancer 
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activity, the most common screening methods employed cytotoxicity tests against a panel 
of cancer cell lines to reveal compounds with the highest toxicity activity.  
 
Cytotoxicity test is a screening method that typically uses permanent cell lines for 
ranking acute toxicities of parent compounds based on the basal cytotoxicity theory (i.e. 
chemical exert their acute toxic effects by interfering with basic cellular functions that are 
common to all mammalian cells (Barile and Cordona, 1998).  It can also be used to assess 
the potential of bioactivation (generation of reactive and toxic metabolites) by using pairs 
of cells line and metabolic competent cell type, such as primary cultured hepatocytes 
(Gomez-Lechon et al., 2001) or metabolic enzyme-transfected cells lines (Drobna et al., 
2005).   
 
In past years, a number of methods have been developed to study cell viability and 
proliferation in cell culture. The most convenient, modern assays have been optimized for 
the use on microtiterplates (96-well format). This miniaturization allows many samples to 
be analyzed rapidly and simultaneously. Colorimetric and luminescene based assays allow 
samples to be measured directly in the plate using a microtiter plate reader or ELISA plate 
reader.   
 
Cytotoxicity assays have been developed using different parameters associated with 
cell death and proliferation such as the integrity of the cell membrane, which can be 
measured by cytoplasmic enzyme activity released by damage cells. Another cytotoxicity 
assays was developed based on metabolic activity of viable cells using 3-(4, 5-
dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide (MTT) which can be reduced to a 
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blue colored formazan. Another parameter using neutral red, NR (3-amino-dimethylamino-
2methyl-phenazine hydrochloride) has been used previously for the identification of vital 
cells in cultures (DeRenzis and Schechtman, 1973). This assay quantifies the number of 
viable, uninjured cells after their exposure to toxicants based on the uptake and subsequent 
lysosomal accumulation of the supravital dye, neutral red over a range of concentration. 
Alteration of the cell surface or sensitive lysosomal membrane can lead to lysosomal 
fragility or other changes which are irrevisible.  
 
Quantification of the dye extracted from the cells is done both by direct cell counts 
and by protein determinations of cell population (Borenfreund and Puerner, 1986). The 
amount of NR dye accumulated can be extracted from the lyososomes and quantitative 
spectophotometrically and compared to NR dye recovered from untreated control cell 
culture. Thus the assay can be applied to determine the cytotoxicity effects of a series of 
extracts (Riddle el al, 1986). The results are expressed as ED50 values which can be 
extrapolated from dose-response curves.  The ED50 values refer to the effective dose (µg/ml 
or mol/L) required to inhibit the proliferation of cell culture by 50%. Linear regression was 
applied to correlate log-transformed in-vitro cytotoxicity data.  
 
2.7 Human Papillomavirus  
Human Papillomavirus (HPV) is an 8 kilobase naked DNA virus beloging to the 
family Papillomaviridae.  It is a non-enveloped virus with double stranded DNA of about 
55 nm in diameter. Human papillomaviruses (HPVs) infect epithelial cells of the skin and 
mucous membranes, and have been linked etiologically to cervical abnormalities including 
precancers, cervical cancer, warts, and recurrent respiratory papillomatosis (Burd, 2003). 
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HPVs are also associated with other malignancies such as squamous cell carcinomas of the 
anus, vulva, vagina, penis, and head and neck (Arends et al., 1990).  HPV infect basal cells 
in mucosa or skin, through micro lesion, and it is strongly dependent on differential status 
of the epithelium for its viral life cycle which is for the development of cervical cancer.   
HPV are grouped by genotypes where they are characterized by degree of DNA 
sequence homology within specific viral genes. HPV types are considered distinct if their 
genomes have less than 90% homology in the DNA sequence of the L1 open reading frame 
(ORFs) (Bonnez and Reichman, 2005). HPV genomes contain about 10 designated ORFs . 
The ORFs are located on a single strand of the viral DNA.  
The HPV genome is divided to early (E), late (L) and the long control regions 
(LCR). Figure 2.1 shows the genetic map of HPV. Region encodes viral proteins which 
function in viral DNA replication, transcriptional regulation and cellular tramsformation. 
LCR contain cis-regulatory elements such as important transcriptional enhancers and the 
origin of DNA replication (zur Hausen, 1996; Howley, 2001, Howley and Lowy, 2001).  
The L region contains information for viral capsid proteins. The papillomavirus 
capsid (the protein shell that encloses the viral DNA) is composed of 360 copies of the L1 
protein (Late 1: the major capsid protein) and approximately 12 copies of the L2 protein 
(Late 2: the minor capsid protein) (Bonnez, 1997).  
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Figure 2.1: The genetic map of HPV (Howley and Lowy, 2001) 
One copy of the double-stranded viral DNA is located inside the capsid shell.  Five 
copies of the L1 protein combine to form a capsomer, and then 72 capsomers combine with 
one copy of viral DNA and 12 copies of the L2 protein at the center of each capsomer to 
form the infectious virus particle (Figure 2.2). The virus particle is an icosahedron which 
means that the capsomers are packed symmetrically in a regular arrangement, such that the 
virus particle can be rotated around several axes, but the appearance of the virus particle 
remains the same.   
 
                   Figure 2.2: Organization of L1 and L2 proteins in the HPV particles  
(Bonnez 1997) 
 
 
There are more than 100 distinct types of HPV that have been identified to date. 
Approximately 50 of these infect the epithelial membranes of the anogenital tract (Franco 
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et al., 2001 and Chan et al., 2002). Genital HPV strains are divided into two groups, based 
on their oncogenic potential and ability to induce viral associated tumors. The strains 
termed ―high-risk strains‖ (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68) are 
associated with intraepithelial neoplasia which more likely to progress to severe lesions and 
cancer (Franco & Ferenczy, 1999). Low-risk strains (HPV 6, 11, 42, 43, and 44) are 
associated with condylomata and low-grade cervical changes, such as mild dysplasia. 
Lesions due to low-risk HPV infection have a high likelihood of regression, little potential 
for progression, and are considered of no or low oncogenic risk (Helmerhorst & 
Meijer,2002).  
Figure 2.3 shows the phylogenetic relationship based on DNA sequence of the gene 
for the L1 proteins between high-risk and low-risk HPVs (de Villiers et al., 2004). There 
are 2 main groups of high-risk HPVs (species 5, 7, 6, and 9) and 2 main groups of low-risk 
HPVs (species 3, 13, 1, 8, and 10). For example, HPV-6 and HPV-11 (both low-risk 
typesare closely related to each other and are in the same species. HPV-6 and HPV-11 are 
the most common low-risk types of HPV, especially associated with warts. 
Cervical cancer is one of the most common neoplastic diseases affecting women, 
with a combined worldwide incidence of almost half a million new cases annually, second 
only to breast cancer (Fronco  et al., 2003).  HPV 16 is the most carcinogenic and most 
prevalent genotype detected in high grade squamous intraepithelial lesions high-grade 
cervical intraepithelial neoplasia and cancer of the uterine cervix (McFadden & Schumann, 
2001). 
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Figure 2.3: Phylogenetic Tree of the Sequences of High- and Low-risk Types of HPV 
High-risk types of HPV are indicated with orange boxes, and low-risk types of HPV are 
indicated with blue boxes. (de Villiers, et al.,2004) 
 
High-grade cervical intraepithelial lesions are most commonly associated with HPV 
16, yet these strains are also frequently found to be the etiologic factor in minor lesions and 
mild dysplasia (McFadden and Schumann, 2001). HPV 16 is the predominant strain in 
almost all regions of the world, with the exception of Southeast Asia, where HPV 18 has 
the highest prevalence (Janicek & Averette, 2001). HPV 16 alone accounts for more than 
50% of HPV infections (Jestreboff and Cymet, 2002). The targets of E6 proteins, which are 
expressed by HPV type 16 virus, are specific cellular transcription factors [p53, Rb family, 
cyclin-dependent kinase 2 (CDK 2), cyclins E and A] that regulate the cell cycle at the G1 
checkpoint. The cell-cycle regulators, targeted by the oncogenes of tumor viruses play a 
major role in the control of G1–S progression in mammals. 
 
In recent years, development of antiviral products for certain highly pathogenic 
viruses with limited available treatments, such as viruses that may have biothreat potential, 
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is critically important and challenging. Antiviral drugs are a class of medication used 
specifically for treating viral infections. Like antibiotics, specific antivirals are used for 
specific viruses. Antiviral drugs are one class of antimicrobials, a larger group which also 
includes antibiotic, antifungal and antiparasitic drugs. They are relatively harmless to the 
host, and therefore can be used to treat infections. For example, Metarhizium anisopliae is 
an entomopathogenic fungus that secretes different types of destruxins (Kou et al., 2005).  
Several studies demonstrated that destruxins have insecticidal (Roberst, 1981), phytotoxic, 
antiviral, nematocidal, and immunomodulating activities (Jegorov et al., 1992). Destruxin 
B has suppressive effects on hepatitis B virus surface antigen gene expression in human 
hepatoma cells (Chen et al., 1997).  
 
2.7.2 Immunohistochemistry 
 
 Immunohistochemistry has emerged as a powerful investigative tool that can 
provide supplemental information to the routine morphological assessment of cells and 
tissues.  The use of immunohistochemistry to study cellular markers that define specific 
phenotypes has provided important diagnostic, prognostic, and predictive information 
relative to diseases status and biology. There are numerous immunohistochemistry methods 
that may be used to localize antigens.  The selection of a suitable method should be based 
on parameters such as the type of specimen under investigation and the degree of sensitivity 
required.   
 
Immonohistochemistry is the localization of labelled antibodies as specific reagents 
through antigen-antibody interactions that are visualized by a marker such as fluorescent 
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dye, enzyme, radioactive element and collodal gold. The peroxidase –labeled antibody 
method, introduced in 1968, was the first practical application of antibodies to paraffin-
embedded tissues and overcome some of the limitations of earlier fluorescent antibody 
method (Nakene, 1968). These pioneering studies using enzyme labels instead of fluorocent 
dyes opened the door to the development of modern methods of immunohistochemistry. 
The early immunohistochemistry approach used polyclonal antibody which was often in 
short supply and sometimes exerted significant variations. There are two ways to detect 
viral antigen; the direct method uses only one virus-specific antibody which is directly 
labelled wiith an indicator (fluorescein or alkaline phosphatase) and indirect method which 
uses two antibodies, one virus-specific antibody to bind the viral antigen and the second 
antispecies antibody to be labelled with the indicator (Lakeman, 1997). 
 
In 1981, a new generation of immunohistochemical methods emerged with advent 
avidin-biotin methods, which remains widely used today (Hsu et al., 1981). All avidin-
biotin methods rely on strong affinity of avidin or strepavidin for the vitamin biotin.  
Strepavidin (from Streptomyces avidinii) and avidin (from chicken) both possess four 
binding sites for biotin. The biotin molecule is conjugated easily to antibodies and 
enzymes.  In the avidin-biotin complex (ABC) method secondary antibodies are conjugated 
to biotin and function as links between tissue-bound primary antibodies and an avidin-
biotin-peroxidase complex (Heras et al., 1995).  
 
In a similar method, the labelled strepavidin-biotin (LSAB) method also utilizes a 
biotinylated secondary antibody that links primary antibodies to a strepavidin-peroxidase 
conjugate. Since avidin is a glycoprotein and has an isoelectric point (pI) of 10, it has a 
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density to non-specifically bind to lectin-like and negatively charged tissue components at 
physiological pH. It has been largely replaced today by streptavidin. The test samples are 
incubated with primary specific antibody against the viral antigen. Then a secondary 
biotinylated antibody capable of binding to the primary antibody followed by Horse-
raddish peroxidase (HRP) enzymes – conjugated with avidin or strepavidin to form a biotin 
–strepavidin HRP complex. Finally the test samples were exposed to a 3‘-diaminobenzidine 
tetrahydrochloride (DAB) substrate.  Upon reaction with HRP, the DAB subtrate will form 
a nondiffusing and insoluble dark brown precipitate at the site of the viral antigen (Forghani 
and Hagens, 1995). In both methods a single primary antibody subsequently is associated 
with multiple peroxidase molecules, and because of the large enzyme-to-antibody ratio, a 
considerable increase in sensitivity is achieved compared to direct peroxidase-comjugated 
method. 
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3.0 MATERIALS AND METHODS 
 
3.1 Penicilliopsis sp. Culture and Maintenance 
 
The mycelial cultures of Penicilliopsis sp. (KUM60280) was maintained on Malt 
Extract Agar, MEA (as described in Appendix A) slants and deposited at the Mycological 
Laboratory, Institute of Biological Sciences, Faculty of Science, University of Malaya.  
 
3.2  Production of Mycelial Biomass 
 
Mycelial inoculum for liquid fermentation was prepared by inoculating centrally a 
plug taken from the outer rim of a mycelial colony onto Glucose-Yeast-Malt-Peptone agar, 
GYMP (Appendix A) and incubated for 4 days at 25
o
C. Then, seven –mm plugs cut from 
outer rim of the mycelia colony using a sterile cork borer was aseptically inoculated into 
50ml sterile GYMP in 250ml Erlenmeyer flasks. The inoculated mycelial were incubated at 
25
o
C for seven days on shaker incubator (Sanyo, Orbital Incubator) rotating at 200 rpm. 
After incubation, mycelia broth was harvested and freeze-dried.  
 
3.3  Preparation of Extracts 
 
Dried mycelia biomass was crushed into powder and extracted by soaking twice in 
methanol and dichloromethane (DCM) separately. Approximately 150ml methanol 
(Mallinckrodt Chemicals, USA) or dichloromethane was poured into 250ml Erlenmeyer 
flasks containing powdered mycelia biomass and shaken for 48 hours in rotary shaker 
rotating at 200 rpm at 25
o
C. The mixtures were then filtered through (Whatman No. 1). The 
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methanolic or DCM filtrate was dried using a Büchi RotavaporR-114 (Switzerland) to yield 
the methanolic or DCM crude extract. 
 
3.4 Determination for Antimicrobial Activities in Penicilliopsis sp. 
 
3.4.1  Microorganisms Tested 
 
Gram-positive pathogenenic bacteria comprising of Bacillus subtilis, B. cereus and 
Staphylococcus aureus, Gram positive oral bacteria, Streptococcus sanguis, S. mutans and 
S. mitis) and Gram-negative bacteria comprising of Pseudomonas aeruginosa, P. vulgaris 
and Escherichia coli were used as test organisms. Fungal species comprising of Candida 
albicans, C. parapsilosis and Saccromyces pombe were used to determine antifungal 
activities. The microorganisms tested were inoculated from Mycological Laboratory, 
Institute of Biological Sciences, Faculty of Science, University of Malaya.  
 
 
3.4.2 Preparation of Bacteria and Fungal Inoculum 
 
Mueller-Hinton Agar nd Muller- Hinton Broth (MHB) (Appendix A) were used to 
grow Gram-positive bacteria. Sabouraud liquid medium (Appendix A) and Sabouraud 
dextrose agar (SDA) were used for growing of fungi. Inoculum was prepared by picking 
colonies from 24 hours old cultures. The density was adjusted by spectrophotometer to that 
of 0.5 McFarland standard at a wavelength of 530 nm to yield a stock suspension of 1 x 10
6
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colony forming units per ml (cfu/ml) for bacterial suspensions and 2.5 x 10
3
 cfu/ml 
intended for fungi. 
 
3.4.3 Antimicrobial Activity of Penicilliopsis sp. 
 
Antibacterial and antifungal activity of crude extracts was determined using disc 
diffusion assays. Modified agar diffusion method (Bauer et al., 1966) was used to 
determine antibacterial and antifungal activities. Penicilliopsis sp. extracts were dissolved 
in dimethylsulphoxide (DMSO) to obtain a concentration of 20mg/mL. DMSO 10% did not 
inhibit growth of bacteria and fungi. Briefly, a suspension of the test microorganisms (0.1 
ml of 1 x 10
6
 cfu/ml for bacteria and 0.1 ml of 1 x 10
5
 cfu/ml for fungi and yeast) was 
lawned on appropriate agar in Petri plates (Muller-Hinton agar for bacteria and sabouraud 
dextrose agar for yeast). Sterile filter paper disc (6mm diameter) was impregnated with 
20µl of the extract and then placed on the inoculated plates. Plates lawned with bacteria 
were incubated for 24 hours at 37
o
C and 48 hours for fungi and yeast at 35
o
C.  
 
Commercial antibiotic namely Chloromphenicol (30µg/disc), Streptomycin 
(30µg/disc) and Kanamycin (30µg/disc) (Sigma, Madrid) were used as antibacterial 
standards while nystatin (100U Sigma, Madrid) was used as antifungal standard to 
determine the sensitivity for microbial species tested. The diameter of inhibition zones were 
measured in millimeters (ml). Inhibition zone diameters around each disc were measured 
and recorded at the end of the incubation time. The values measurements of inhibition 
zones were the average of three replicates. 
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 3.5 Antioxidant Activity of Penicilliopsis sp. 
 
The methanol and dichloromethane crude extracts were tested for antioxidant activity 
using 1-1-diphenyl-2-picrylhydrazyl (DPPH
.
) radical scavenging assay and reducing power 
assay. 
 
3.5.1  Scavenging Activity on 2-2-diphenyl-2-picrylhydrazyl (DPPH
.
) Radicals  
 
DPPH radical scavenging activity was determined based on a procedure described 
by Brand-Williams et al. (1995) with a slight modification. One mM DPPH
. 
(Sigma-
Aldrich) solution was prepared by dissolving 0.0039g of DPPH powder in 10ml methanol. 
The 1 mM solution was further diluted to 0.06 mM with methanol. Stock solutions of each 
dried extracts were prepared by dissolving 0.05g of dried extract in 1 ml methanol. An 
aliquout of 3.9ml of DPPH was added up to methanol and dichloromethane extracts to 
obtain 10-100mg/ml of solution. 
 
The solution was mixed vigorously using a Shimadzu UV-1240-UV-Vis 
spectrophotometer (Shimadzu, Kyoto, Japan). The decrease in absorbance was recorded at 
0, 1, 2 minutes and every 15 minutes until the reaction reached a plateau. The steady state 
was determined by one-way analysis of variance (ANOVA) to compare decrease in 
absorbance values. Reaction reached a steady state after 1 hour at room temperature. in 
Antioxidant activity was compared with L-ascorbic acid (Sigma-Aldich) and Butylated 
hydroxyanisole, BHA (0.1mM-1.0mM) as a positive standard. All determinations were 
39 
 
performed in triplicates. The scavenging activity on DPPH was expressed as percentage 
radical scavenging calculated follows: 
 
% radical scavenging effect = A0-AS  
 
     
 
A0 refers to the absorbance of 0.06mM DPPH methanolic and DCM solution only whereas 
AS the absorbance of the reaction mixture. The radical stock was prepared fresh daily. 
 
3.5.2 Reducing Power Assay 
 
The reducing power of Penicilliopsis sp. extracts were determined according to a 
modification method of Oyaizu (1986).  Briefly, each extract in varying amounts of 5mg, 
10mg, 15mg and 20mg was dissolved in one ml of methanol and subsequently 2.5 ml of 
0.4M phosphate buffer (pH6.6) and 2.5ml 0f 1% (w/v) solution of potassium ferricyanide 
were added. The mixtures were incubated in water bath at 50
o
C for 20 minutes. Following 
this 2.5ml of 10%, (w/v) trichloroacetic acid solution was added and the mixture was then 
centrifuged at 650-x g for 10 minutes. Than, 2.5 ml aliquot of the upper layer was 
combined with 2.5 ml distilled water and 0.5 ml (500ul) of a 0.1% (w/v) solution of ferric 
chloride. Absorbance of reaction was read spectophotometrically at 700 nm. Increased 
absorbance of the reaction mixture indicates greater reducing power. 
 
 
 
 
% radical scavenging effect =  A0-AS 
             X 100 % 
                A0 
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3.5.3 Statistical Analysis 
 
Data were recorded as means ± standard deviations and analysed by SPSS (version 
14 for Windows). One-way analysis of variance (ANOVA) was carried out to test for any 
significant differences between the means; the mean values of antioxidant activities 
between two extracts or two treatments were analyzed by independent-samples t-test. P-
values less than 0.05 were considered to be statistically significant [*P <0.05; **P< 
0.01;***P<0.001]. All analyses were performed in triplicates.  
 
3.6 Total Phenolic Content of Extract  
 
Total phenolic compound were determined as gallic acid equivalents (GAE) Follin-
Ciocalteau‘s phenol reagent (2.0N), L-ascorbic acid, BHA and Gallic acid (3, 4, 5-
trihydrobenzoic acid, Formula Molecule= C7H6O5, Formula Weight = 170.12) were 
obtained from Sigma-Aldrich, whereas sodium carbonate (Na2CO3) was purchased from R 
& M Chemicals, United Kingdom. Solutions were prepared in distilled water at room 
temperature.  
 
This method was a modification of that reported by Singleton and Rossi (1965). 
Two hundred and fifty microliters of 10% Follin-Cicocalteau‘s phenol reagent were added 
to 250µl of extracts (0.1 mg/ml) in 1.5 ml disposable plastic cuvettes and then mixed 
thoroughly. After three minutes, 500 µl of 10 % Na2CO3 was added to the mixture. After 
incubating for an hour in dark condition, the intensity of the blue colour was measured at 
750 nm. A standard calibration curve was constructed using gallic acid with concentrations 
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1-5 µg/ml. Blank consisting of distilled water plus reagent without the extract samples  and 
with L-ascorbic acid and BHA was prepared.  
 
The absorbance values were converted to total phenolic content calculated based on 
the gallic acid calibration curve and expressed as gallic acid equivalents (GAE) in mg/g 
extracts. Three replicates were prepared for each concentration of extracts. The total of 
phenolic content was calculated using a calibration curve of gallic acid. 
 
3.7 Evaluation of Cytotoxic Activity of Penicilliopsis sp. Extracts 
 
3.7.1 Preparation of Stock Solution 
 
Twenty milligrams of methanol and dichloromethane crude extract, respectively, 
were weight dissolved in 1 ml of Dimethyl Sulfoxide (DMSO, Sigma) in a 1.5 ml provial to 
provide a stock solution of 20 mg/ml and stored at -20
o
C (Freezer, Acson) until use. 
 
3.7.2 Cell Lines 
 
In this study, six cancer cell lines and one normal cell line were used to analyse the 
cytotoxic activity of Penicilliopsis sp. (KUM60280).  Human mouth epidermal carcinoma 
cell line (KB), Human epidermal carcinoma of cervix cell line (CaSki), Human colorectal 
cancer cell line (HT29), (HCT119), Human  breast cancer cell line(MCF7), Human ovarian 
cancer cell line (SCOV3) and Human fibroblast cell line which is a normal cell line 
(MRC5) were purchased from American Tissue Culture Collection (ATCC, USA). 
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3.7.3 Maintenance of Cell 
 
The cells were examined daily using an inverted microscope (Olympus) for signs of 
bacterial or fungal contamination. The 20% supplemented Rosewell Park Memorial 
Institute (RPMI) 1640 medium in the flask was replaced with fresh 10 % supplemented 
RPMI 1640 medium when colour change was observed. The cells were maintained in 10% 
supplemented RPMI 1640 medium in a 5% CO2 incubator. Media change was performed at 
a twice-weekly interval or based on the colour changes from time to time. The cells were 
subcultured when the cell concentration exceeded 2 X 10
6
 per ml. 
 
3.7.4  Revival of Cells Lines 
 
A provial containing cell line was removed from liquid nitrogen tank and plunged 
into a beaker of ice. It was then transferred to 37
o
C water bath (Grand Instruments) for 
quick thawing using gentle hand agitation. The cells were transferred into a centrifuge tube 
(Falcon) containing 7 ml of 20% supplemented medium 199, DMEM, Mccoys, and RPMI 
1640 medium and spun at 1000 rpm for 5 minutes. The supernatant was discarded and the 
cell pellet was resuspended in 5 ml of 20% sumplemented medium and incubated in a 25 
ml tissue culture flask at 37
o
C in a 5% carbon dioxide (CO2) water jacketed incubator 
(Jouan). 
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3.7.5  Subcultivation of Cells 
 
Adherent cells attached and formed a single layer in a culture flask. The medium in 
the tissue culture flask was discarded. Confluent cells were washed using 10 ml of sterile 
phosphate buffered saline (PBS) pH 7.2. The cells were detached from the flask by 
incubating with 1 ml 0.25% accutase solution and 3 ml PBS solution for 5 to 10 minutes at 
37
o
C, and then sharply tapped to detach the cells from the flask. After the cells have 
detached, the cell suspension was transferred into a centrifuge tube and centrifuged for 5 
minutes at 1000 rpm. The supernatant was discarded and the cell pellet was resuspended  in 
3 ml of 10% supplemented medium. The uspension was split and transferred into different 
culture flasks each containing 7 ml culture media. The flasks were incubated at 37
o
C in a 
5% CO2 incubator. 
 
3.7.6 Cryopreservation of Cells 
 
The cells with subconfluent or confluent monolayer were fed with fresh 10% 
supplemented RPMI 1640 medium 24 hours before freezing.  The medium in the tissue 
culture flask was discarded and the cells were washed with 10 ml of sterile PBS pH 7.2.  
The cells were detached from the flask as described in section 3.7.5.   After centrifugation, 
supernatant was discarded and the cell pellet was resuspended in 3 ml of freezing medium.  
The cell suspension was aliquoted in 1 ml amounts into 3 provials.  The provials were left 
to stand in ice and kept in a polystyrene box.  The box was kept in -70
o
C freezer overnight 
after which, the provials were transferred and stored in a liquid nitrogen tank. 
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3.7.7  Serial Dilution of Extract Stock Solution 
 
Aliquots of 10 µl from the extract stock solution (20 mg/ml) was diluted in 90 µl of 
sterile distilled water to produce a stock concentration of 2,000 µg/ml.  It was then further 
diluted with 10% DMSO to provide final concentrations of 200 µg/ml and 20 µg/ml.  
 
 3.7.8 Incubation of Cell Lines with Extracts 
 
The cells with confluent monolayer were detached from the flask as described 
before.  Cells were detached from the flask with 0.25% accutase and washed in culture 
medium. The cell pellet was obtained by centrifugation at 1000 rpm for 5 minutes to 
remove fine dye crystals. After centrifugation, the supernatant was discarded and the cell 
pellet was resuspended in 1 ml of 10% supplemented medium to produce a stock cell 
suspension. For cell enumeration, 100 µl of the stock cell suspension was transferred into a 
provial with 900 µl of 0.4% tryphan blue and mixed well. The haemacytometer (Scherf) 
was covered with a glass cover slip and 20 µl of the suspension with dye was loaded at two 
edges of the cover slip so that it could flow into the chambers by capillary action at the 
area. The haemacytometer was then examined under an inverted microscope and unstained 
viable cells were counted.  
 
The cell suspension at a concentration of 3 x 10
4
 cells/ml (concentration of 5 x 10
4
 
cells/ml was used for cell lines) was prepared according to the formula below: 
 
 
P1  x 10
5
 x V1 =  P2 x V2 
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P1 : Average number of viable cells counted from the haemacytometer 
10
5
 : Counting chamber conversion factor & dilution factor dye 
V1 : Volume of stock cell suspension needed 
P2 : The desired cell concentration in the cell suspension 
V2 : Volume of 10% supplemented medium used for seeding 
 
Cells were then plated in 96-well microtiter plate, at a concentration 30 000 cells/ml 
for each cell lines in a total volume of 190-200µl. A total of 200 µl of the cell suspension 
with known cell density was transferred into every well of a 96-wells plate (Nunc) and 
incubated overnight in a 5% CO2 incubator 37
o
C to allow the cells to adhere before 
addition of the extracts. The plate was observed under microscope and medium was 
discarded when the cells achieved 60-70% confluence. The cells were then incubated with 
fresh extracts solution serially diluted in 10% supplemented medium at varying 
concentrations (1, 10, 25, 50, 75 and 100 µg/ml) for 72 hours at 37
o
C in a 5% CO2 
incubator. All the tests were performed in triplicates and untreated cells with just growth 
medium served as negative controls.  
 
3.7.9 Neutral Red Cytotoxicity Assay 
 
After the 72 hours incubation period, the medium with or without extracts was 
removed followed by the addition 200 µl of neutral red (NR) dye into respective wells. The 
plate was further incubated for 3 hours to allow maximum uptake of neutral red dye by the 
viable cells. The dye was discarded and the cells were rapidly washed with pre-warmed 
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washing solution. The neutral red dye was extracted from the viable cells by adding 200 µl 
of warm NR resorb solution into every well and was left to incubate at room temperature 
for 30 minutes in a bench top incubator (LT biomax 500). The plate was then gently 
agitated on a microplate shaker (LT Biomax 500) for 15 minutes and the optical density 
(OD) was determined spectophotometrically at 540 nm using an ELISA reader (Titertek 
Multiskan ® MCC/340). 
 
The mean of measurements for each concentration was determined (n=3). The 
average data of the triplicates for each extracts concentration was expressed in terms of 
killing percentage relative to negative controls. The percentage of inhibition of each of the 
extract was calculated according to the following formula: 
 
 
 
The ED50 is the concentration of extract that causes 50% inhibition or cell death. 
ED50 for each extract was extrapolated from the dose-response curves plotted. An extract 
that gave ED50 of 20µg/ml or less is considered active for the cytotoxic assay (Gerah et 
al.,1972). Linear regression analysis was used to compute the concentration of test agent 
needed to reduce the absorbency of NR by 50% (termed the midpoint cytotoxicity, or 
Effective Dose, ED50).   
 
 
 
% of inhibition = OD control – OD sample 
   OD control  X 100% 
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3.8 Analysis for Anti-HPV 16 E6 Oncoprotein Activity of Penicilliopsis sp.  
 
3.8.1 Cell Line 
 
The cell line used in this study was the HPV16 containing cell line, CaSki. 
 
3.8.2 Serial Dilution of Penicilliopsis sp. Stock Solution 
 
Five different extract concentrations were used to study the anti-HPV 16 activity of 
Penicilliopsis sp. (KUM60280) extracts.  Aliquotes of 180 µl from each extract stock 
solution (20 mg/ml) was diluted in 2.82 ml of sterile distilled water to produce a stock 
concentration of  200 µg/ml. Further dilution was carried out to provide final concentration 
of 600 µg/ml, 450 µg/ml, 300 µg/ml, 150 µg/ml and 75 µg/ml respectively. 
 
3.8.3  Incubation of CaSki Cells with Extracts 
 
One milliliter of serially diluted stocks were added into five tissue culture flasks 
containing cultured CaSki cells and 2 ml of fresh 10% supplemented RPMI 1640 medium 
to provide a final concentration of 200 µg/ml, 100 µg/ml, 50 µg/ml and 25 µg/ml, 
respectively. The cells were left to incubate with the extracts in a 5% CO2 incubator at 37
o
C 
for 72 hours. CaSki cells not treated with extracts of Penicilliopsis sp.(KUM60280) served 
as negative control. 
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3.8.4  Fixation of CaSki onto Slides 
 
After 72 hours incubation period, the Caski cells were detached from the flask as 
described in 3.7.6. After centrifugation, the supernatant was discarded and the cell pellet 
was resuspended in 1.2 ml of PBS pH 7.2. A total of 30µl of cell suspension was 
transferred into every well of three teflon coated slides (Immuno-cell Int.). The slides were 
left to dry overnight at room temperature. The slides were fixed with acetone (System) at -
20
o
C until use in immunohistochemical staining. 
  
 
3.8.5 Detection of Human Papillomavirus (HPV) E6 protein Using 2-step Indirect 
Avidin-Biotin Immunoperoxidase Method 
 
Immunohistochemical staining was carried out using the labeled Strepavidin Biotin 
Peroxidase kit (LSAB) and 3‘-diaminobenzine tetrahydrochloride (DAB) Substrate system 
(Dako) according to specifications describe. All washing steps required constantshaking 
and incubationwith reagents were carried out in a humidified chamber.  
 
The slides were immersed in decreasing concentrations of ethanol (Schlarlau) – 100 
%, 95%, 90% and 80% for 2 minutes each and then washed in PBS pH7.6 for 10 minutes 
on the rocker platform (Bellco Biotechnology). The surrounding areas of each well were 
blotted dry using filter paper (Whatman) and 50 µl of 3 % hydrogen peroxide (BDH) was 
added onto every well to remove the endogenous peroxidase activity. The slides were 
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incubated for 10 minutes at 37
o
C followed by washing in PBS pH 7.6 for 5 minutes on the 
rocker. 
 
The surrounding areas of wells were blotted dry and 10 µl of diluted HPV16 E6 
antibody (Chemicon), were diluted in 1:50 with sterile distilled water (10 µl/ml + 490 µl/ml 
sterile distilled water) added to four wells on the one end of the slide. 30µl of sterile 
distilled water was added to four wells on the other end of slide. These cells, which were 
untreated with the anti-HPV 16-18E6 antibody, served as negative controls. The slides were 
incubated again in a bench top incubator (LT Biomax 500) at 30
o
C for 1 hour. Later, slides 
were
 
washed twice in PBS pH 7.6 for 15 minutes each. Afterwards 30µl of secondary 
antibody were added to each well followed by incubation at 37
o
C for 30 minutes then 
added with 30µl biotinylated anti-mouse and anti-rabbit immunoglobulin (Dako) 
streptavidin – horse radish peroxidase (Dako).   
 
Subsequently slides were washed in PBS pH 7.6 for 5 minutes, after which, the 
wells were filled with 30µl of  liquid DAB substrate – cromogen (Dako) which is mixture 
of 40µl of chromogen and 2ml of DAB subtrate and incubated for 20 minutes at 37
o
C until 
the desired colour intensity developed. The slides were rinsed in distilled water and then 
counterstained with Mayer‘s hematoxylin solution (Fluka) for two minutes. The slides were 
rinsed again with distilled water and then immersed into 30% ammonia solution (Systerm) 
for 10 seconds. After the last rinse with distilled water, the slides were mounted with pre-
warmed glycergel (53
o
C, Dako), covered with covered slip and left to dry overnight in the 
dark. The stained slides were visualized under the light microscope (Olympus).  
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4.0 RESULT 
 
 
4.1 Crude Extract and Mycelia Biomass from Penicilliopsis sp. 
 
 Penicilliopsis sp. (KUM60280) sporulated after 4 days grown on Glucose-Yeast-
Malt-Peptone (GYMP) agar at 25
o
C. Colony diameter on GYMP reached 5 cm diameter, 
velvety, with crenate, subsurface margins, amber to honey, with synnemata abundantly 
produced branched with pure yellow pigments diffused into media, while the underslide 
turn yellowish in colour. Plate 4.1 showed sporulation of synemata region on surface of 
colonies.  Figure 4.1 (a and b) illustrates the morphology of Penicilliopsis sp. showed oval 
shaped conidia located in an ascus.  
 
 
 
 
Plate 4.1 Penicilliopsis sp. (KUM 60280) mycelia growing on  
Glucose-Yeast-Malt-Peptone agar 
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Figure 4.1 (a and b) Morphology of Penicilliopsis sp. using light microscope of 400 X 
magnification.     
 
Table 4.1 shows the yield of mycelial biomass and the yield of crude extract in 
methanol and dichloromethane from culture grown in Glucose-Yeast-Malt-Peptone 
(GYMP) media. The amount of mycelial biomass for methanol extract was 31.19 
gram/gram whereas mycelial biomass for DCM was 19.93 gram/gram. Extract yield in 
methanol showed the higher percentage then DCM. This might indicate that most of the 
solutes in methanol extract were polar components.   
Conidia Ascospores 
Conidial  head 
b 
a 
Synnematous 
conidiogenou
s structures 
40µm 
40µm 
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Table 4.1 Percentage yield crude extracts of Penicilliopsis sp. (KUM60280)  
 
 
 
 
4.2  Antimicrobial Activity of Penicilliopsis sp.   
 
Antibacterial and antifungal activities of crude extracts were determined using 
modified disc diffusion method (Bauer et al., 1966). A total 12 microorganisms consisting 
of Gram positive and Gram negative bacteria and yeast were tested. The in-vitro  
antimicrobial activity was assessed by the diameter size of inhibition zones.   
 
Standard antibiotics (streptomycin, kanamycin, chloramphenicol and nystatin) were 
used as a positive control. The dimethyl sulfoxide (DMSO) used to dissolvethe extract was 
a negative control and did not show any inhibiton against all microorganisms. Table 4.2 
presents the zones of inhibition produced by Penicilliopsis sp.extracts. 
 
Methanol extract did not show any antimicrobial activity against all test 
microorganisms. Dichloromethane extract of Penicilliopsis sp. displayed low inhibition 
activity against all test bacteria and fungi ranging from 7-9.7mm diameter. Inhibition zones 
against all microorganisms were detected in halo, indicating a weak inhibition. The most 
Type of Extract Mycelial biomass 
(g/ml) 
Crude extract dry 
weight (g) / (g) 
             
Methanol 350.28 31.19 
Dichloromethane 218.63 19.93 
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susceptible species was Bacillus cereus, followed by Escherichia coli, while the highest 
antifungal activity was agains S. pombe. 
 
4.3 Antioxidant Activity of Penicilliopsis sp.  
 
Extracts of Penicilliopsis sp. were subjected to screening for their possible 
antioxidant activity. Antioxidant capacity was evaluated using DPPH
.
 free radical- 
scavenging and reducing power.   
 
 
4.3.1 DPPH
.
 Scavenging Effect  
 
The DPPH
.
 scavenging method, utilizes free radical with a characteristic absorption  
at 517 nm which measures a violet solution. Antioxidant activity was defined as the amount 
of antioxidant necessary to decrease the initial DPPH
.
 concentration by 50%, which 
represent the effective dose (EC50). Figure 4.2 illustrates the free radical scavenging of 
extracts tested at various concentrations.   
 
Free radical scavenging of ascorbic acid and butylated hydroxylanisole (BHA) were 
also determined and acts as a positive control (Figure 4.3).  Ascorbic acid and BHA were 
observed to react quickly with the DPPH
.
 radical.   
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Figure 4.2 DPPH scavenging activity of Penicilliopsis sp. mycelia extracts.   
 
The EC50 value of positive control which is ascorbic acid is 0.1 mM or 100 µM 
equivalent to 0.078 mg/ml while EC50 for BHA is 0.2 mM or 200 µM which is equivalent 
to 0.11 mg/ml. Free radical scavenging activity of the extracts exhibit dose dependent 
response. The EC50 was determined after 60 minutes i.e. the time taken for maximum 
DPPH radical being scavenged (Appendix).   
y = 1.866x
R² = 0.9932
y = 0.9905x
R² = 0.9879
0
10
20
30
40
50
60
70
80
90
100
0 10 20 30 40 50 60 70 80 90 100 110
%
 r
a
d
ic
a
l 
s
c
a
v
e
n
g
in
g
 e
ff
e
c
t
Concentration(mg/ml)
Methanol Dichloromethane
55 
 
 
Table 4.2 Antimicrobial activity of the extract of Penicilliopsis sp. (KUM60280) (20 µg/disc) against test microorganisms using disc 
diffusion method 
  Diameter of inhibition zone (mm)   
Microorganisms/ Extract Dichloromethane Kanamycin Streptomycin Chloromphenicol Nystatin 
Gram positve bacteria      
Bacillus cereus 9.67 ± 1.70 29.3 ±  1.40  30.0  ± 0.40 33.7  ± 1.20 NT 
Bacillus subtilis 8.33 ± 0.5 2.20 ± 0.80 2.30 ±  1.40 3.30 ±  3.60 NT 
Satphylococcus aureus 8.33 ±  0.5 2.57 ±  1.70 1.93 ±  1.40 23.0 ±  4.90 NT 
      
Oral bacteria (Gram +ve)      
Streptococcus mitis 7.30 ± 1.20 23.7 ± 1.20 18.0 ± 0.4 18.0 ± 1.40 NT 
Streptococcus mutans 7.70 ± 0.40 15.30± 1.70 18.7 ± 1.70 16.7 ± 1.90 NT 
Streptococcus sanguis 8.30 ± 0.50 17.7 ± 0.05 18.7 ± 2.60 17.7 ± 1.20 NT  
      
Gram negative bacteria      
Escherichia coli 8.70 ± 1.20 26.0 ±1.20 20.3 ±  1.40 24.7 ±  2.10 NT 
Pseudomonas aeruginosa 8.33 ± 0.4 29.0 ± 0.8 24.7 ± 1.90 33.7 ± 1.90 NT 
Pseudomonas vulgaris 7.67  ± 0.4 31.0 ± 2.90 22.3 ± 0.50 33.0 ± 1.40  NT 
      
Antifungal Activity      
Candida albican 7.00 ± 0.8 NT NT NT 26.3 ± 0.8 
Candida parapsilosis 7.67 ± 0.5 NT NT NT 2.78 ± 0.9 
Saccromyces pombe 8.00± 0.5 NT NT NT 2.20 ± 1.60 
                                         Values are means + SD (mm) of three separate experiments; ‗-‗no inhibition zone; NT: not tested 
*No inhibition were shown by the methanol extract 
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The concentrations of methanol extract were 15, 25, 30, 40 and 50 mg/ml, and 
dichloromethane extracts were 10, 30, 50, 70 and 100 mg/ml. The effective concentrations 
of each fraction and reference compound required to scavenge 50% of the DPPH radicals. 
The methanol extracts showed better DPPH radical scavenging activity rather than 
dichloromethane extract. The polar methanol extract was able to reduce the stable free 
radical 2,2-diphenyl-1-picrylhydrazine (DPPH) to yellow-colored DPPH with an EC50 26.8 
mg/ml whereas EC50 of dichloromethane extract was 50.5 mg/ml. 
 
 
Figure 4.2 DPPH scavenging activity of ascorbic acid and butylated hydroxylanisole  
(BHA).  
 
 
The synthetic antioxidant agent, ascorbic acid and BHA still have shown better 
antioxidant activity because the EC50 values of ascorbic acid and BHA were 0.078 mg/ml 
and 0.11 mg/ml respectively. The effective concentration of extracts and positive control 
required to scavenge 50% of the DPPH radical, (the EC50 values) are presented in Table 
y = 6.389x
R² = 0.9947
y = 4.668x
R² = 0.974
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0 0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16 0.18 0.2%
 r
a
d
ic
a
l 
s
c
a
v
e
n
g
in
g
 e
ff
e
c
t
Concentration (mg/ml)       
Conc. of Ascorbic acid (mg/ml) Conc. of BHA (mg/ml)
57 
 
4.3. Methanolic extract showed higher scavenging activity with EC50 value of 26.8 mg/ml 
while dichloromethane extract showed EC50 value of 50.5 mg/ml. 
 
Table 4.3 Scavenging effects of fractions of Penicilliopsis sp. extracts on DPPH
.
 radical 
Sample EC50 (mg/ml) 
Dichloromethane 50.5 
Methanol 26.8 
Ascorbic Acid 0.078 
BHA 0.11 
 
 
 
4.3.2 The Reducing Power Assay 
 
Total reducing power was determined as described by Oyaizu, (1986) with 
modification. An increased in absorbance of the reaction mixture indicated increased 
reducing power. Figure 4.4 kshows the reductive capabilities of Penicilliopsis sp. extracts 
compared to ascorbic acid and butylated hydroxylanisole (BHA) as a positive control.  
  
 The reducing power of both crude extracts from Penicilliopsis sp. increased with 
the concentration. The reducing powers of methanolic extract and dichloromethane extracts 
from mycelia were 1.161 and 0.431 mg/ml, respectively at 5 mg/ml. However, the reducing 
power of ascorbic acid and BHA showed excellent reducing powers of 1.933 and 2.539, 
respectively which are significantly higher than crude extracts from Penicilliopsis sp. 
(KUM60280) at the same concentration.         
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Figure 4.4 Reducing power of Penicilliopsis sp. extracts, ascorbic acid and butylated 
hydroxylanisole (BHA). Average of three replicates. 
 
 
 
4.4 Total Phenolic Content assay 
 
The Follin-Ciocalteau was used to measure the total phenolics content in the 
Penicilliopsis sp. (KUM60280) extracts. Results were expressed as gallic acid equivalents 
(mg/100ml). The antioxidant activity has been found to be correlated to the total phenolic 
content due to their property of scavenging free radicals. Therefore, the correlation of total 
phenolic content of the Penicilliopsis sp. extracts.  
Table 4.4 Amounts of total phenolics content equivalent gallic acid (GAE) in g GAE/100 g 
extracts 
Samples       g/(GAE)/100 g extracts 
_________________________________________________________________________ 
Methanol extract       107.87 
Dichloromethane extract      58.43 
BHA         9723.25 
Ascorbic acid        932.9 
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   The total phenolic content of Penicilliopsis sp. (KUM60280) extracts expressed as 
a gallic acid equivalent (GAE) per 100 gram extracts are presented in table 4.4. The total 
phenolics content in methanol extract was significantly higher than dicloromethane, 
respectively, found to be 107.87g GAE/100 g methanol and 58.43g GAE/100 g extract, 
respectively.  The result indicated that the higher the antioxidant activity obtained for the 
methanol fraction, the higher is the total phenolic content.    
    
 
4.5 Cytotoxicity Activity of Penicilliopsis sp.  
 
In the present study, methanol and dichloromethane extracts from Penicilliopsis sp. 
were evaluated for their cytotoxic activities against human mouth epidermal carcinoma cell 
line (KB), human epidermal carcinoma of cervix cell line (CaSki), human colorectal cancer 
cell line (HT29), (HCT119), human breast cancer cell line (MCF7)  human ovarian cancer 
cell line (SCOV3) and normal human fibroblast cell line. The cells were grown using 
different medium such as RPMI 1640, DMEM, Mc COYs, MEM, DMEM and 199 
medium. The cell lines were incubated with methanol and dichloromethane extract of 
Penicilliopsis sp. at varying concentrations of 1, 10, 25, 50, 75, and 100 µg/ml for 72 hours 
in a 5 % carbon dioxide (CO2) at 37
o
C.  The negative controls consisted of cells lines not 
treated with Penicilliopsis sp. extracts.   
 
The cells were exposed to the extracts at various concentrations. Generally, based 
on NR assay, methanol and dichloromethane extracts of Penicilliopsis sp. were considered 
not cytotoxic against the cell lines tested. Figures 4.6 to 4.12 were plotted, to show different 
cytotoxic profiles when treated using different crude extracts from Penicilliopsis sp. The 
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cytotoxic effect of crude extracts of Penicilliopsis sp. against cell lines increased with 
increasing concentrations of extracts, showing killing percentage.  The present study shows 
that the pattern of killing percentages shown by methanol extract ranged from 20-30 % at 1 
µg/ml, 30—40% at 10 µg/ml, 40-55 % at 50 µg/ml, 55-60% at 75 µg/ml and 70-80 µg/ml 
at 100 µg/ml. While dichloromethane extract ranged from 1-10% at 1 µg/ml, 20-30% at 10 
µg/ml, 30-40% at 25 µg/ml, 40-50% at 50 µg/ml, 50-60% at 75 µg/ml and 60-70% at 100 
µg. 
 
 The cytotoxic data obtained were expressed as a killing percentage relative to 
negative controls. ED50 value is the concentration of extract which results in 50% killing of 
cells. The ED50 values were extrapolated from the dose-response curves plotted cell 
employed more than 50% cytotoxicity inhibition. Results exerted that the ED50 of MCF7 
cells line against crude methanol extract and dichloromethane extract was 56.221µg/ml and 
48.912 µg/ml, respectively. The ED50 of methanol extract in MCF7 appeared is more potent 
compared their ability to retard more than 50% of cell growth even at low concentration as 
1 µg/ml. It was followed by CaSki cell; results show that the extracts marked cytotoxicity 
effect was 40.183 µg/ml for methanol and 41.451 µg/ml for dichloromethane.  KB cells 
lines exerted less cytotoxicity effects by given lower ED50 were 40.882 µg/ml for methanol 
and 30.063 µg/ml dichloromethane respectively. Table 4.5 stated ED50 values of 
Penicilliopsis sp. (KUM60280) extracts against various cell lines. Graph plotted (Figure 4.6 
to 4.12) shows that ED50 values were all more than 20 µg/ml indicating that they are not 
strongly cytotoxic. 
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Figures 4.5 (a,b, and c) show negative control consist of untreated CaSki, KB and HT 29 
cells respectively. Negative controls exhibited normal proliferation rate and showed no sign 
of abnormal death after 72 hours incubation. 
 
 
                       Figure 4.5(a)  Figure 4.5(b) 
                                      Figure 4.5(c) 
 
Figure 4.5: Photomicrograph of: (a): KB cells incubated in Medium 199 (b): CaSki cells 
incubated in RPMI 1640 medium (c): HT29 cells incubated in RPMI 1640 medium  
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Figure 4.6 The in vitro growth inhibitions of MCF7 cells by crude extract of Penicilliopsis 
sp.  determined by using the Neutral Red Cytotoxic assay.  
 
 
 
 
Figure 4.7 The in vitro growth of CaSki cells by crude extract of Penicilliopsis sp. 
determine by the Neutral Cytotoxic assay. 
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Figure 4.8 The in vitro growth of KB cells by crude extract of Penilcilliopsis sp. determine 
by the Neutral Red Cytotoxic assay.  
 
 
 
Figure 4.9 The in vitro growth inhibitions of HT29 cells by crude extract of Penicilliopsis 
sp. determine by the Neutral Red Cytotoxic assay.  
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Figure 4.10 The in vitro growth of SCOV3 cells by crude extract of Penicilliopsis sp. 
determine by the Neutral Red Cytotoxic assay.  
 
 
Figure 4.11 The in vitro growth of HCT119 cells by crude extract of Penicilliopsis sp. 
determine by the Neutral Red Cytotoxic assay. 
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Figure 4.12 The in vitro growth of MRC5 cells by crude extract of Penicilliosis determine 
by the Neutral Red Cytotoxic assay. 
 
 
Table 4.5 ED50 values of Penicilliopsis sp. (KUM60280) extracts against various cancer  
cell lines. 
 Penicilliopsis KUM60280 
ED50 (µg/ml) 
Methanol Dichloromethane 
MCF7 56.221 48.912 
CaSki 40.183 41.451 
KB 40.882 30.063 
   
 
Human mouth epidermal carcinoma cell line (KB); Human epidermal carcinoma of 
cervix cell line (CaSki); Human breast cancer cell line (MCF7) 
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4.6 Anti-HPV 16 E6 Oncoprotein Activity in Penicilliopsis sp.  
 
 Methanol and dichloromethane extracts of Penicilliopsis sp. were evaluated for 
potential anti humanpapilloma virus, HPV16 E6 activity.   CaSki cells were treated with the 
extracts at 4 different concentrations (25 µg/ml, 50 µg/ml, 100 µg/ml and 200 µg/ml) for 72 
hours at 37
o
C.  
 
The 3 steps indirect HRP – DAB immunoperoxidase technique using anti HPV-16 
E6 monoclonal antibody were successfully applied in this study to analyze the expression 
of E6 oncoprotein still present in treated and untreated Caski cells. The staining color was 
categorized as: no stain (-), weak (+), moderate (2+), strong (3+) and very strong (4+). The 
suppressing effect of the testing extract is considered as weak for (4+), moderate for (3+), 
moderate for (2+) and high for (+).   The presence of E6 oncoprotein was noted based on 
the appearance of reddish brown stain either in nuclear or cytoplasmic regions of Caski 
cells. 
 
Negative controls used in this study were the CaSki cells not treated with the extract 
and incubated with anti- HPV 16, E6 monoclonal antibody (Negative control A) as well as 
CaSki cells not treated with the extracts and not incubated with monoclonal antibody 
(Negative Control B).  The results of staining of both CaSki cells incubated with or without 
HPV monoclonal antibody are shown in Plate 3 (a and b). All CaSki cells incubated with 
monoclonal antibody show strong reddish brown (4+) stains and were morphologically 
intact. This is due to high expression of the HPV16 E6 oncoprotein. Negative control A 
was found to exert strong reddish-brown stain indicated high expression of E6 oncoprotein. 
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While the CaSki cells which incubated without HPV monoclonal antibody appears to be 
unstained (-).  
 
 
 
Plate3(a) 
 
 
 
Plate 3(b)       
 
Plate 3 (a) CaSki cells not treated with Penicilliopsis KUM60280 extracts but 
incubated with anti-HPV-16 E6 monoclonal antibody.  Cells showed very strong 
staining (4+) in the nuclear and cytoplasmic regions (400x) (b) CaSki cells not treated 
with Penicilliopsis sp. (KUM60280) extracts without anti-HPV-16 E6 monoclonal 
antibody.  Cell showed no staining (-) was observed under 400x magnification. 
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The different intensities of staining reflected the expression of HPV-16 E6 
oncoprotein still presenting of CaSki cells treated with different extracts at various 
concentration. The results were compared between crude extracts of Penicilliopsis sp. 
(KUM60280) and negative control (Figure 4.13).  Table 4.6 and table 4.17 summarized and 
the morphology the expression of HPV-16, E6 oncoprotein analyzed extra treated CaSki 
cells. 
 
 
 
(*Negative control A for CaSki not treated with Penicilliopsis sp.) 
 
Figure 4.13: Staining intensities of CaSki cells treated with Penicilliopsis sp. 
 
Classification for the staining intensity as: no stain (0), weak (1+), moderate (2+), strong 
(3+) and very strong (4+) 
 
Stanining intensity of the reddish-brown stains in CaSki cells decreased from 4+ to 
2+ when treated with 50µg/ml and 100µg/ml of methanol extract. Than futher decreased to 
+ was observed at higher concentration of 200µg/ml. This suggest that methanol extract of 
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Penicilliopsis sp. (KUM60280) was successful in producing some inhibition on the 
expression of HPV16 E6 oncoprotein on a dose dependent manner where higher extract 
concentrations produce stronger suppression on the oncoprotein. 
  
 On the other hand, in CaSki cells treated with dichloromethane extract of 
Penicilliopsis sp. the staining intensity of the reddish brown stains, decreased only slightly 
from 4+ to 2+ when treated with 50µg/ml. No futher decrease was observed at 100µg/ml 
and 200µg/ml. These suggest that dichloromethane extract only slightly suppressed the 
expression of HPV16 E6 oncoprotein. 
 
In this present study, CaSki cells treated with methanol and dichloromethane of 
Penicilliopsis sp. remained morphologically intact at lower concentrations but some lyses 
was observed at 100µg/ml and 200µg/ml (Figure4.6 and 4.7). Generally, the HPV 16 E6 
oncoprotein was not suppressed in CaSki cells by the crude extracts of Penicilliopsis sp. 
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Table 4.6 Anti HPV effect methanol extract of Penicilliopsis  sp. on CaSki cell 
 Concentration of 
extract (µg/ml) 
Intensity of 
reddish-brown 
stain 
Morphology of 
cells 
 
 
 
 
25 
 
 
3+ 
 
No intact and no 
lysis 
 
 
 
 
50 
 
 
2+ 
 
 
No intact and no 
lysis 
 
 
 
 
 
100 
 
 
 
 
200 
 
 
2+ 
 
 
 
 
+ 
 
 
 
No intact and 
some lysis 
 
 
 
No intact and 
majority of cell 
was lysis 
CaSki cells treated with methanol extract of Penicilliopsis sp. (KUM60280) (400x 
magnification) 
Note: Classification for the intensity of staining as no stain (-), weak (+), moderate (2+), 
strong (3+) and very strong (4+) 
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Table 4.7 Anti HPV effect of dichloromethane extract of Penicilliopsis sp. on CaSki cell  
 Concentration of 
extract (µg/ml) 
Intensity of 
reddish-brown 
stain 
 
Morphology of 
cells 
 
 
 
 
 
25 
 
 
 
 
50 
 
3+ 
 
 
 
 
 
2+ 
 
 
No intact and no 
lysis 
 
 
 
Intaact and no 
lysis 
 
 
 
 
 
100 
 
 
 
 
2+ 
 
 
 
Some intact and 
some lysis 
 
 
 
 
200 
 
 
2+ 
 
 
Some intact and 
some lysis 
 
CaSki cells treated with dichloromethane extract of Penicilliopsis sp. (KUM60280) 
(400x) Note: Classification for the intensity of staining as no stain (-), weak (+), moderate 
(2+), strong (3+) and very strong (4+) 
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5.0 DISCUSSIONS 
 
 
5.1 Yield of Mycelial Biomass and Crude Extract of Penicilliopsis sp.  
 
The process efficiency is qualitatively related to extraction yield. Incubation of 
Penicilliopsis sp. at 25
o
C for 48 hours under shaking condition gives optimum growth of 
mycelial biomass. Penicilliopsis sp. sporulated immedieatly on day seven because medium 
was incubated under shaking condition where nutrient uptake is more efficient, giving more 
rapid growth and that growth become homogenous (Tuner, 1971).  
 
In the present study, the yield crude extracts of Penicilliopsis sp. gives optimum 
growth of mycelium. It was noted, the difference yield of crude methanol extract which was 
notably higher propagation than dichloromethane as listed in Table 4.1. This might indicate 
that most of the solutes in methanol crude extract were polar components compared to 
dichloromethane, an indication of the presence components in the Penicilliopsis sp. Besides 
the evaluation of the quantitative efficiency of extracting process, the yield values are not 
directly related to their qualitative efficiency.   Peterson and Bridge (1994) reported known 
that culture medium can affect the presence or absence of secondary metabolites and/or 
their level of production by fungi. 
 
In has been reported, fungal culture has potential advantages for higher mycelial 
and polysaccharide production in a more-compact space over a shorter incubation time and 
availability of convenient control with less chance of contamination (Kim et al., 2003; Lee 
et al., 2004). Many investigators have attempted to obtain optimal submerged cultures for 
mycelial polysaccharides production from several fungi (Dong & Yao, 2007). To the best 
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of our knowledge, the nutritional requirements for submerged culture of P. baumii Pilát 
have not been demonstrated. To achieve higher yield of mycelial polysaccharide in a 
culture, it is a prerequisite to design an optimal production medium and a set of optimal 
process operating conditions. 
 
 
5.2 Antimicrobial Activity of Penicilliopsis sp.  
 
This study was carried out using agar diffusion assay and modified slightly by 
Bauer et al. (1966). The antimicrobial effect of crude extracts of Penicilliopsis sp. were 
tested against six Gram positive bacteria including three oral bacteria, three  species of 
Gram negative bacteria and three species of fungal as summarized in Table 4.2. The 
antimicrobial activity of methanol and dichloromethane extracts of Penicilliopsis sp. was 
shown by the size of inhibition zone (mm). However, both of crude extracts of 
Penicilliopsis sp. failed to show antibacterial and antifungal activity.  From the results, 
methanolic extracts of Penicilliopsis sp. did not exhibit antibacterial and antifungal activity 
(Table 4.2) whereas the dichloromethane extracts exhibited weak inhibition zone less than 
10 mm. Based on the results, it was possible to conclude that the crude dichloromethane 
extract had a mild activity and broader spectrum than those of methanol extract.  
 
Cintia et al. (2007) reported that the tested bacterial and fungi grew inside the halo, 
indicating a weak inhibition power. The maximal inhibition zones of Penicilliopsis sp. 
extracts were Bacillus cereus followed by Escherichia coli. As reported by Cosentino et al. 
(1999) and Karaman et al.  (2003), Gram positive bacteria are more sensitive to crude 
extract than Gram negative bacteria. Previous studies have suggested that the differences in 
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cell wall structure between Gram positive and Gram negative bacteria might be the reason. 
The Gram negative bacteria have an outer membrane acting as a barrier to many 
environmental substances, including antibiotics (Palombo and Sample, 2001). The 
difference in sensitivity between Gram-positive and Gram-negative bacteria might be 
attributed to the differences in morphological constitutions between these microorganisms. 
Gram-negative bacteria have an outer phospholipidic membrane containing 
lipopolysaccharide components. On the other hand, the Gram-positive bacteria only have 
an outer peptidoglycan layer which is not as an effective permeability barrier as the former. 
 
As reported by Aziz et al. (2007), the antibacterial properties of Laetiporus 
sulphureus were not as effective as the commercial drugs. But, microorganisms become 
resistant to antibiotics overtime. Previously become it has been demonstrated that 
mushrooms show antimicrobial effects (Hur et al., 2004; Ishikawa et al., 2001; Sheena et 
al., 2003).  
  
Developing new antimicrobial agents that are cell selective is a major challenge, 
especially when the target is the cell membrane (Gregory et al., 2006). The results of in-
vitro antifungal activities showed that all target compounds had no potent in-vitro 
antifungal activities. A variety of studies have been conducted in an attempt to isolate 
natural antifungal substances with potential pharmaceutical utilization, and to develop and 
design new synthetic or semi-synthetic drugs (Lopez-Garcia et al., 2005; Viejo-Diaz et al, 
2005; Alcouloumre  et al., 1993). The mycelium contains compounds with wide-ranging 
antimicrobial activity (Aziz et al, 2002).  Sung et al. (1999) reported the antifungal activity 
of peptide against various pathogenic fungi isolated from patient and fluconazole-resistant 
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fungi, its synergism with other antifungal drugs, the rate of fungicidal activity, and its 
cytotoxicity against mammalian cell. 
  
 5.3 Antioxidant Activity of Penicilliopsis sp.   
 
Recently, numerous reports have described antioxidants and compounds with 
radical-scavenging activity present in fruits, vegetables, herbs, and cereal extracts (Gray et. 
al., 2002; Hou et. al., 2005 and Nutiila, 2003).  A wide variety of fungi produced novel 
antioxidant compound (Ishikawa, 1992; Yang et al., 2002). These include Penicillium 
roquefortii, Aspergillus, Candidus, Mortirella sp., Emericella falconensis and fungi of the 
genus Acremonium. In the present study, Penicilliopsis sp. demonstrated antioxidant 
properties of methanolic and dichloromethane from mycelia biomass when analysed using 
a range of testing system in vitro; DPPH assay and the reducing power assay.  
 
The results suggest that Penicilliopsis sp. extracts have potent antioxidant activities. 
Single electron transfer reactions (DPPH and FRAP) can be relatively slow and measure 
relative percent decrease in product rather than kinetics or total antioxidant capacity. The 
inhibition of accumulation of colored reagents (DPPH) in the presence of antioxidants is 
not always linearly correlated to antioxidant concentrations. Due to the complexity of the 
oxidation-antioxidation processes, it is obvious that no single method is capable of 
providing a comprehensive picture of the antioxidant profile of studied sample.   
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 5.3.1 DPPH
.
 Free Radical Scavenging Activity 
 
Free DPPH, a stable free radical with a characteristic absorption at 517 nm, was 
used to study the radical scavenging effects of extracts. As antioxidants donate protons to 
these radicals, the absorbance decreases. The decrease in absorbance is taken as a measure 
of the extent of radical scavenging. Radical-scavenging capacities of the extracts, measured 
by DPPH assay, are shown in Figure 4.2. It was observed, that in line with the increase seen 
in the amount of methanol and dichloromethane extracts of Penicilliopsis sp., an increase in 
DPPH free radical-scavenging occurred. The inhibition value increases with concentration. 
Vitamin C oxidation was compared with those of Penicilliopsis sp. extracts, Vitamin C and 
BHA.  
It was found that inhibition values of both Penicilliopsis sp. crude extracts and the 
standards increased with concentration. For example; at 20mg/ml concentration, methanolic 
and dichloromethane crude extracts of Penicilliopsis sp., showed 35%, 25% of scavenging 
effect, whereas 20 mg/ml concentrations of BHA and ascorbic acid showed 19% and 12%, 
respectively. While at 50 mg/ml concentrations, 91% for methanol, 51 % for 
dicholoromethane and 56% and 66% respectively for ascorbic acid and BHA. According to 
this, it is possible that the high inhibition value of the Penicilliop sp.extracts were due to 
the high concentration of phenolic compounds (see Table 4.3). Previously in a study 
performed on Laetiporus sulphureus (Bull.) Murrill. extracts, inhibition values both of L. 
sulphureus ethanol and the standards increased parallel with the elevation of concentration 
in the linoleic acid system (Aziz et al., 2006). 
In this study, the methanol extracts showed higher antioxidant activities than 
dichloromethane extracts. Polar compounds extracts exhibited stronger activity than non 
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polar compounds in accordance with free radical scavenging activity results. This result 
could be explained by the ‗polar paradox‘ (Frankel et al., 1994).  According to this theory, 
polar antioxidants would be more effective in non-polar media, and non-polar antioxidants 
more active in polar media. As a result, methanol extracts have excellent capacity in both 
DPPH
.
 and FRAP.    
The antioxidant properties assayed herein were summarized in Figure 4.3 and 
results are normalized and expressed as EC50 values (mg various extracts per ml) for 
comparison among the crude extracts with positive control as illustrated in Figure 4.2.   
Scavenging effects of Penicilliopsis sp. extracts on DPPH
. 
radicals increased 
concentrations. The decrease in the concentration of DPPH
.
 radical due to the scavenging 
ability of extracts from Penicilliopsis sp. and standard is very significant (P<0.01). With 
regard to EC50 values of antioxidant activities by DPPH
.  
radical scavenging activity, 
effectiveness was in a descending order: BHA>ascorbic acid>methanol> dichloromethane.  
The EC50 scavenging activities were 0.078 > 0.107 > 26.80 > 50.48 mg/ml, respectively.  
The results indicated that crude extracts of Penicilliopsis sp. (KUM60280) have a 
noticeable effect of scavenging free radicals.  However, the scavenging effect of BHA and 
ascorbic acid are higher than crude extracts of Penicilliopsis sp.  
This study showed crude extracts from Penicilliopsis sp. have some components 
within the fragments significantly strong radical-scavenging component and have a potency 
to become one of antioxidant medicine. Various extracts might react with free radicals, 
particularly the peroxy particle which is the major propagators of the autooxidation chain of 
fat, thereby terminating the chain reaction (Frankel, 1991; Gordon, 1990; Shahidi and 
Wanasundra, 1992). Methanolic extracts from edible mushroom species might react with 
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free radicals, which are the major initiator of the autoxidation chain of fat, thereby 
terminating the chain reaction (Frankel, 1991; Gordon 1990).  Activity of natural 
antioxidants has been shown to be involved in termination of free radicals reaction 
(Shimada et al., 1992).  Furthermore Herraiz et al. (2003) found that an essential amino 
acid  L-trytophan could react with phenolic aldehydes in food to form phenolic tetrahydroβ-
carboline alkaloids that scavenged 2,2-azinobis/93-ethyl-benzothiazoline)-6-sulfonic acid 
(ABTS) effectively.   
 
Antioxidants are believed to play a significant role in the body defense system 
against free radical. Free radicals are harmful by-products generated during normal cellular 
metabolisms, which could initiative oxidative damage to body (Abidi and Ali, 1999; 
Halliwell & Gutteridge, 1999). Besides playing an important role in physiological systems, 
antioxidants have been used in food industry to prolong the shelf life of foods, especially 
those in rich in polyunsaturated fats.  These components in the food are readily oxidized by 
molecular oxygen and are major cause of oxidative deterioration, nutritional losses, off 
flavour development and discolorization. The additional of synthetic antioxidant such as 
butylated hydroxylanisole (BHA), butylated hydroxyltoluent (BHT), propyl gallate etc has 
been widely used industrially to control lipid oxidation in food (Gurdip et al., 2007).   
 
 
5.3.2 The Reducing Power 
 
 The reducing capacity of a compound may served as a significant indicator of its 
potential antioxidant activity. For the measurement of the reductive ability, this study has 
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investigate the Fe
3+
 and Fe
2+
 transformation in the presence of the crude extracts of 
Penicilliopsis sp. using the method of Oyaizu (1986). The reducing power of both 
Penicilliopsis sp. extracts increased with the concentrations. The increase in absorbance of 
the reaction mixture was interpreted as increase in reducing activity of the Penicilliopsis sp. 
and the result was compared to gallic acid (positive control). Figure 4.4 indicates the 
reductive capabilities of crude methanolic and dichloromethane.  Among the crude extracts 
methanolic showed better reducing power than dichloromethane, i.e 1.161 and 0.431 mg/ml 
respectively.   
 
According to the present study, it is suggested that methanol fraction has 
remarkable potency to donate electron to reactive free radicals, converting them into more 
stable nonreactive species and terminating the free-radical chain reaction.  However, BHA 
and ascorbic acid showed higher activities than methanol and dichloromethane.  The 
reducing power of crude extracts and standard compounds followed the order 
BHA>ascorbic acid>methanol>dichloromethane.   
 
Previous studies observed a direct correlation between activities and reducing power 
of certain fungus extracts (Pin, 1998; Pin et. al., 1999).  Pin (1998) stated the reducing 
properties are generally associated with the presence of reductones which have been shown 
to exert antioxidant action by breaking the free radical chain by donating a hydrogen atom 
(Gordon, 1990).  Reducing power assays often used to evaluate the ability of natural 
antioxidant to donate electron (Dorman et al., 2003, Yildirim et al., 2000).  The antioxidant 
activity of putative antioxidants have been attributed to various mechanisms, among which 
are prevention of chain initiation, binding of transition metal ion catalysts, decomposition 
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of peroxides, prevention of continued hydrogen abstraction, reductive capacity and radical 
scavenging (Diplock,  1997).  
 
5.4 Total Phenolics Contents in Extract of Penicilliopsis sp.  
 
The DPPH
. 
assay reflects the ability of phenolics present in crude extracts of 
Penicilliopsis sp. to inhibit radical formation. All the results were expressed as gallic acid 
equivalents (g /(GAE) / 100g). Total phenol were the major naturally occurring 
antioxidants components founds and their contents were in descending order BHA 
(9723.25 g/(GAE)/100g) > ascorbic acid (932.9 g/(GAE)/100g) > Methanol (107.87 
g/(GAE)/100g) > Dichloromethane (58.43 g/(GAE)/100 g) (Table 4.4).  
 
Phenol is important plants constituent because of their scavenging ability due to 
their hydroxyl groups (Hatano et al., 1989). It is important, therefore to determine the total 
phenol content in order to evaluate the possible synergistic or antagonistic effect on their 
contribution to the total phenol to the total of antioxidant capacity. The phenolics 
compounds may contribute directly to the antioxidative action (Duh et al., 1999). Vitamin 
C is highly bioavailable and is therefore the most important water-soluble antioxidant in 
cells and efficient scavenger of reactive oxygen species (Halliwell, 1996). Phenol such as 
BHT and gallate were known to be effective antioxidants (Madhavi et al., 1996).  
 
 Due to their scavenging abilities on free radicals and chelating abilities on ferrous 
ions (Latilo and Fraga, 1998), phenols contain good antioxidant properties, antimutagenic 
properties and anticancer properties (Ahmad & Mukhtar, 1999).  Yen et al., (1993) found 
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that the antioxidant activity of the methanolic extract from peanut hulls correlated with it‘s 
content of totals phenols. This activity is increased with presence of polyphenols in 
particular (Behera et al., 2005). Therefore the higher contents of total phenols in the crude 
extracts were responsible for their better antioxidant properties.   .  
 
   Phytochemicals, such as phenolic compounds are considered beneficial for human 
health, decreasing the risk of degenerative diseases by reduction of oxidative stress and 
inhibition of macromolecular oxidation (Silva et al., 2004; Pulido et al, 2000 and Tseng et 
al, 1997). Phenolic constituents, such as flavanoids, phenolic acids, and tannin are well 
known for their high antioxidant activity (Rice-Evants et al., 1996). Many studies indicate 
linear relationship between total phenolics and antioxidant activivty (Djeridane et al, 2006; 
Kim et al., 2004 and Kim, et al, 2006).  
 
In this study it was found that phenolic compounds are major contributors to 
antioxidant activity, since total phenolics and antioxidant activity showed a good 
correlation coefficient of R
2
=0.9972 (Appendix B).  A similar result was previously 
observed by Kim et al., (2003). Ana et al., 2007 reported that it is important to determine 
the total phenolic content in order to evaluate the possible synergistic or antagonistic effect 
on their contribution to the total antioxidant capacity.  Phenolics measured by the Folin-
Ciocalteau assay are essentially simple soluble phenolics. The release of hydrophobic 
phenolic antioxidants and ellagic acid enrichment is thought to occur through the 
molecular rearrangement of simple phenolics and hydrolysis of complex polyphenols such 
as tannins by fungal enzyme systems (Vettem and Shetty, 2002).   
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Previously, lignin or polymeric phenolic degradation activities were linked to 
phenolic antioxidant mobilization from soybean substrate during solid-state bioprocessing 
by dietary fungi such as Rhizopus oligosporus or Lentinus edodes (McCue et al., 2004).  
Recently, fungus (mushroom) are considered to be a good source of protein and total 
phenolic content such as variegatic acid and diboviquinone, which have been found in 
mushroom (Cheung, et al., 2003).   
 
Correlation of antimicrobial activities to phenolic content, DPPH radical inhibition 
and ellagic acid provides insights into potentially different mechanisms of action of these 
antimicrobials.  Soluble phenolics are thought to exert their antimicrobial effect by causing 
hyperacidification at the plasma membrane interface of the microorganism, which 
potentially results in disruption of the H+-ATPase required for ATP synthesis. Different 
sensitivities of the microorganisms against the phenolic content in the extracts may be 
because of the difference in their membrane structure and associated cell wall differences 
between gram positive and gram negative bacterial species (Vettnem et al, 2004).   
 
  Tannins and hydrolyzed tannins are known to exhibit inhibitory effects on 
microorganisms (Acamovic and Stewart, 1992).  Tannins and their hydrolyzed products 
have been shown to inhibit the growth of microorganism by sequestering metal ions critical 
for the microbial growth and metabolism (Kainja et al., 1998; McDonald, et al., 1996) or 
by inhibiting critical functions of the bacterial membrane such as ion channels and 
proteolytic activity (Muhammed, 1997). 
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5.5 Cytotoxicity Activity of Penicilliopsis sp. Using in vitro Neutral Red  
 
Cytotoxic anticancer drug efficacy is contingent upon differences in drug sensitivity 
between normal and tumor tissue. These drugs often small, with little difference between 
the doses required for optimal antitumor activity (effective dose) and that which produces 
unacceptable toxicities in normal cells (Chatelu et al., 2003). The cytotoxicity of the 
studied extrcts requires special attention in view of the major damage they cause to cell 
functions, which result in the ability of cell to proliferate. In vitro cytotoxicity assays are 
useful to define basal cytotoxicity, for example the intrinsic ability of a compound to cause 
cell death as a consequence of damage to several cellular functions. The cytotoxic effect 
may be considered an earlier indication of cellular damage, with possible biological 
consequences.  The ideal anticancer agents would exert minimal adverse effects on normal 
cell with maximal capacity to kill tumor cells and/or inhibit tumor growth. Inhibition of 
proliferation of tumor cells without inducing cell death could potentially reduce 
cytotoxicity to normal, non-tumor host cells, particularly if those normal cell are low-  or 
non- proliferating (Ruen, 2006).   
 
Cytotoxicity test using human cell lines are appropriate for screening of the 
potential hazardous effects of a large number of chemicals on human health. It have been 
reported in past years, a numerous of methods number have been developed to study cell 
viability and proliferation in cell culture. In the search for new drug for anticancer the most 
common screening methods employ cytotoxicity tests against cell lines. Therefore, it seems 
reasonable to utilize, at the primary screening stage, in vitro toxicity assays to select the 
least toxic compounds among the most active ones (Joanna et al, 2005). There are many in 
vitro methods, which have been developed to test toxicity towards particular cells. One or 
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more of them can be chosen if specific type of toxicity is expected.  One of the tests used 
for evaluating toxicity of new anticancer agents in vitro, is colony forming unit assay using 
cell from human.  In the drug discovery process, it is desired to find not only the most 
active, but also the least toxic substances. It is important that such selection could be done 
at the very beginning of developmental process, at the stage of in vitro studies.    
 
This study was carried out to evaluate the cytotoxic potential of methanol and 
dichloromethane extracts of Penicilliopsis sp. on human mouth epidermal carcinoma cell 
line (KB), human epidermal carcinoma of cervix cell line (CaSki), human colorectal cancer 
cell line (HT29), (HCT119), human breast cancer cell line (MCF7), human ovarian cancer 
cell line (SCOV3) and normal human fibroblast (MRC5). The method used was in vitro 
neutral red (NR) cytotoxicity assay. This technique is simple and rapid based on the 
lysomal incorporation of NR dye by viable cells assay which can be conveniently carried 
out in 96-well microtiter plates (Borenfreund and Puerner, 1986). The cells cultured were 
observed under micsroscope from time to time to monitor the growth of CaSki cells. Only 
living cells are able to manage the active uptake of neutral red. Visual inspection or staining 
of cells followed by cell counting used in this studies to determine toxic effects of toxicty 
The cells were than incubated with fresh serial diluted extracts 1, 10, 25, 50, 75 and 
100µg/ml when 60-80% confluence in growth was achieved. Based on NR assay, methanol 
and dichloromethane extracts of Penicilliopsis sp. (KUM60280) were considered not 
cytotoxic against the cells line tested.  
 
The results was obtained from NR assay were expressed as effective dose, ED50  
values which refer to the effective extracts concentration that reduce the proliferation of 
cultures by 50% inhibition. Results indicated that the percentage of killing increased with 
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the concentration of extracts tested. The results from ED50 value was extrapolated from the-
dose response curves. Ridell el al., (1986) reported that the dose-response is considered 
more reliable than value based]. Figure 4.6 till 4.12 illustrated cytotoxic activity of crude 
extracts against cell lines. From the graph plotted, ED50 for methanol and dicloromethane 
extracts of Penicilliopsis sp. were all more than 20mg/ml. It shows that crude extracts of 
Penicilliopsis sp. was not actively cytotoxic against cells lines tested. Its might be 
explained because of the cell line‘s origin was huge difference, which implies that the 
sensitivity for exposure with different chemicals might vary as well. The cytotoxic effect 
was elicited by certain metabolite that may be enhanced or reduced by interacting 
metabolites to a different degree for different cells lines. The cell lines were used in this 
study has been used for a long time which cells have changes in their ability. Previous 
study on the anti-tumor activities of Cordyceps species have mainly focused on their water 
or alcohol extracts, which contain mostly polar components (Zhang et al, 2004).   
 
The neutral red (NR) assay was used in this present study was performed after 72 
hours treatment of Penicilliopsis sp. against seven cancer cell lines and one normal cell.  
This technique based on the incorporation of the supravital dye neutral red, into the 
lysosomes of viable cells (Borenfreund, et al., 1995; Babich and Tipton, 2002). Based on 
Riddell et al., (1986), suggested 48 to 72 hours incubation period for cell lines to react with 
extracts using the NR method as compared to 24 hours because the latter may give an 
unacceptable number of false negative indications of cytotoxicity. Short incubation period 
will lead to failure to discriminate between chemicals which have genuinely different 
cytotoxicity. Tryphan blue dye was used as for counting cancer and normal cell lines 
because they are frequently used for toxicological purpose, low cost and quick response. 
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Tryphan blue exclusion is used generally to quantify the reduction in percentage of viable 
cells and the cytotoxic effect.  
   
The literature reports several studies on cytotoxicity of fungal metabolites in 
mammalian cell lines (Dambach et al, 2005 ; Gomez et al, 2001).  It has been discovered 
that an endophytic fungus (Taxomyces andreanae) also produced the anticancer drug 
paclitaxel (Taxol
®
) derived from Pacific yew (Stierle et al., 1995).  Francesca et al., (2004) 
found the toxicity of sixteen fungal metabolites produced by some entomopathogenic fungi 
or biological control fungi agents was evaluated on lepidoptera  Spodoptera frugiperda 
(SF-9). This mycotoxin is extremely toxic to leucocytes and other rapidly dividing cells 
resulting in vivo and in vitro immunosuppressing effects.  Bioactivity-guided fractionation 
of this extract resulted in the isolation of a novel dihydroxanthenone (type of anticancer) 
which is named as globosuxanthone (Kithsiri et al., 2006). Dominique et al. (2002), 
evaluated a new cytotoxic tatralone derivative from Humicola grisea, filamentous fungi 
from wood. Inonotus obliquus (Chaga mushroom), one of the well-known medicinal 
mushroom, has been used as remedies for gastric disorders and cancer and there are many 
reports published on anticancer and anti-inflammatory activities (Wasser and Weis, 1999; 
Hwang et al., 2003; Kim et al., 2006; Chen et al., 2007; Youn et al., 2008). 
 
 
5.6 Anti- HPV 16 E6 Oncoprotein Activity of Penicilliopsis sp.   
 
Cervical cancer is one of the most common neoplastic diseases affecting women, 
with a combined worldwide incidence of almost half a million new cases annually, second 
87 
 
only to breast cancer. Basic and epidemiologic research conducted during the past 15–20 
years have provided overwhelming evidence for an etiologic role for infection with certain 
types of sexually-transmitted human papillomavirus (HPV) as the primary cause of cervical 
cancer. Persistent infection with carcinogenic human papillomavirus (HPV) types is widely 
considered a necessary cause in the development of cervical cancer (Wright and Shiffman, 
2003). The relative risks of cervical cancer following HPV infection as ascertained in case-
control and cohort studies are among the highest in cancer epidemiology (Francoc et al., 
2001).   
 
The E6 oncogene of the HPV-16 is almost regularly expressed in the cervical 
tumours and in the derived cell lines. Oncogene with alteration   properties sepecially 
interacts with the p53 protein and has a direct degradation through the ubiquity pathway 
(Schwarz, 1990; Herrington, 1994). Constant expression of E6 oncoprotein will interfere 
with host cell regulatory proteins and lead the host cell into a proliferative state required for 
malignant transformation (Arends et al, 1998). Therefore, screening for natural compounds 
with HPV-16 E6 oncoprotein suppressing effect is important.  
 
In the present study, the CaSki cells were treated with methanol and 
dichloromethane extracts of Penicilliopsis sp. extracts at varying concentration (25 µg/ml, 
50 µg/ml, 100 µg/ml and 200 µg/ml). The presence of E6 oncoprotein was noted based on 
the emergence of reddish brown stain either in nuclear or cytoplasmic regions of Caski 
cells. Results were interpreted by the intensity of colour of the reddish brown stain. The 
staining color was categorized as: no stain (-), weak (+), moderate (2+), strong (3+) and 
very strong (4+). The appearance of reddish-brown stain indicates the presence of HPV-16 
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E6 oncoprotein in CaSki cells. Generally, all CaSki cells incubated with monoclonal 
antibody was found strong reddish brown (4+) stains and were morphologically intact. This 
is due to high expression of the HPV16 E6 oncoprotein. Negative control A was found to 
exert strong reddish-brown stain indicated high expression of E6 oncoprotein.  
 
In the present study, methanol extract of Penicilliopsis sp. showed stanining 
intensity of the reddish-brown stains in CaSki cells decreased from 4+ to 3+ when treated 
with 25µg/ml and 50µg/ml. Than further decreased to 2+ and + at higher concentration of 
100ug/ml and 200µg/ml, respectively. This shows that methanol extract of Penicilliopsis 
sp. (KUM60280) was able to produce some inhibition on the expression of HPV16 E6 
oncoprotein on a dose dependent manner where higher extract concentrations produce 
stronger suppression on the oncoprotein. The staining intensity of reddish brown in CaSki 
cells treated with dichloromethane extract of Penicilliopsis sp. (KUM60280), decreased 
only from 4+ to 2+ when treated with 50µg/ml. There was no further decreased observed at 
100µg/ml and 200µg/ml. It showed that dichloromethane extract of Penicilliopsis sp. only 
slightly suppressed the expression of HPV16 E6 oncoprotein.  
 
According to Ghasaq et al.(1999), the relatively low level of detection by 
immunohistochemistry can be attributed not only to the lower sensitivity of the method but 
also to factors related to the nature of the antibodies and the nature of the antigenic target. 
First, in malignant lesions, not all of the E6 transcripts are translated into full-length E6 
protein (Nilson, et al., 1996). Second, it is conceivable that fixation and processing of the 
tissues may have adverse effects on the epitope of the E6 protein and their binding 
efficiency has only been tested in vitro. Third, the E6 protein (like E7, the other HPV gene 
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expressed early in the replicative cycle of HPV) has a short half-life thus rapid degradation 
might reduce its detection by immunohistochemistry in our samples.  
 
The technique used in this study to evaluate the presence of HPV 16 E6 oncoprotein 
was the two-step indirect avidin-biotin immunoperoxidase immunocytochemistry method.    
Avidin, is a large glycoprotein, can be labeled with peroxidase and has a very high affinity 
for biotin. Biotin, a low molecular weight vitamin, can be conjugated to a variety of 
biological molecules such as antibodies. The technique involves three layers which is the 
first layer is unlabed. The reagents are readily manufactured in market and no extraordinary 
equipment is required to carry out the staining protocol.  Sometimes false-negative staining 
occur which can attribute the HPV 16 E6 activity by over fixation or overlapping of cells. 
False-positive may be resulted from incomplete elimination of endogenous enzyme 
activity. Endogenous enzyme activity can be suppressed or avoided by pretreatment with 
H2O2 prior to incubation with monoclonal antibody (Forghani and Hagens, 1995). False-
positive results may be seen due to non-immunological binding of protein or substrate 
reaction products. They may also caused by endogenous enzymes such as myeloperoxidase, 
leucocyte alkaline phosphatase and hemoglobin pseudoperoxidase, primarily in frozen cells 
and depending on the type of enzyme label used to visualize the reaction (Elias et al, 1989). 
 
The negative controls were untreated CaSki cells (were not incubated with 
Penicilliopsis sp. (KUM60280) extracts). Some of these cells were incubated with anti-
HPV 16 E6 monoclonal antibody (Negative control A) whereas the others were not 
(Negative control B). The cells incubated with anti-HPV monoclonal antibody exhibited 
very dark reddish-brown stain in the nuclear and or cytoplasm. This indicated that the 
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HPV-16 E6 oncoprotein was intense and highly expressed in untreated CaSki cells.  The 
control not incubated with anti-HPV 16 E6 monoclonal antibody did not exhibit reddish-
brown stain. This correlates well with the absence of specific anti-HPV 16 E6 primary 
antibodies needed to detect the E6 oncoprotein. 
 
In this present study, fresh solvent was used for each run because expected time 
duration influenced the functional stability of biological substance, including 
immunohistochemistry (IHC). Incubation times or temperatures other than those specified 
may give erroneous results. In this study, the temperature of incubation period during 
addition of antibody was decreased from 45
o
C to 30
o
C. Generally, incubation times can be 
extended if little or no background was detected. In IHC, antibody titer and dilution as well 
as incubation time and temperature are tightly interwoven in their effect on staining quality.  
Optimum antibody titer is defined as the highest dilution of an antiserum (or monoclonal 
antibody) that result in maximum specific staining with the least amount of background 
under specific test conditions. This highest dilution is determined primarily by the absolute 
amount of specific antibodies present. The stability of a diluted antibody can vary over time 
depending upon the dilution. Correct dilutions will contribute to the quality of staining if 
they are prepared accurately and consistently. Antibodies should be stored according to the 
conditions detailed on the specification sheet. If frozen antibody are utilized, than repeated 
freezing and thawing should be avoided. Frozen antibodies must be stored in small aliquots 
until periodic assay verification for detect unacceptable changes in reactivity.   In addition, 
phosphate buffered saline (PBS), should not be used as a diluents unless recommended by 
the manufacturer. 
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6.0 CONCLUSION 
 
Fungus is known to produce unusual classes of compounds with a wide variety of 
biological activities (including antimicrobial, antiviral, and antitumor properties). 
Therefore, fungus is very attractive as a potential source of new therapeutic agents. No 
work has been done to investigate the bioactivity of extracts from Penicilliopsis sp. 
mycelia.  
 
In this present study, that extracts of Penicilliopsis sp. (KUM60280) only exhibited 
good antioxidant activity evaluated by DPPH scavenging activity and total reducing power. 
However crude extracts of Penicilliopsis sp. did not exhibit antimicrobial activity. The 
extracts of Penicilliopsis sp. are not actively cytotoxic against human mouth epidermal 
carcinoma cell line (KB), human epidermal carcinoma of cervix cell line (CaSki), human 
colorectal cancer cell line (HT29), (HCT119), human breast cancer cell line (MCF7), 
human ovarian cancer cell line (SCOV3) and normal human fibroblast (MRC5). Further 
evaluation using immunocytochemistry technique showed that the extracts did not suppress 
the expression of HPV 16 E6 oncoprotein in CaSki cells. Although the results from the 
present study are not sufficient to predict the final biological effectiveness of Penicilliopsis 
sp. It nevertheless served as a practical preliminary screening tool to evaluate biological 
activities of Penicilliopsis sp.   
 
Real success in this area will probably only be achieved through an interdisciplinary 
approach, whereby the knowledge is combined with the technology and structural tool for 
mycologists. It should be noted however that not all experiments lead to the discovery of a 
92 
 
totally new chemical compound; occasionally the structural probing reveals a known 
bioactive compounds, although its source might be novel.  
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Appendix A 
 
Preparation of solution, chemical and media 
 
Malt Extract Agar (MEA) 
 
Malt Extract Agar (MEA) agar weighing 13.44 g was dissolved in 400 ml of distilled water 
in an Erlenmeyer flask using a magnetic stirrer.  The solution was poured into universal 
bottles until half full, than autoclaved at 121
o
C for 20 minutes.  To make agar slants, the 
universal bottles were tilted are certain angle to give a reasonable slope.  The agar in the 
bottles was left to harden at room temperature. 
 
 
Potato Dextrose Agar (PDA) 
 
Potato Dextrose Agar (PDA) agar weighing 24 g was dissolved in 400 ml of distilled water 
in an Erlenmeyer flask using a magnetic stirrer.  The solution was poured into universal 
bottles until half full, than autoclaved at 121
o
C for 20 minutes.  To make agar slants, the 
universal bottles were tilted are certain angle to give a reasonable slope.  The agar in the 
bottles was left to harden at room temperature. 
 
 
Muller-Hinton Agar (MHA) 
 
Muller-Hinton Agar (MHA) was agar weighing 38 g was dissolved in 400 ml of distilled 
water in an Erlenmeyer flask using a magnetic stirrer.  The solution was poured into 
universal bottles until half full, than autoclaved at 121
o
C for 20 minutes.  To make agar 
slants, the universal bottles were tilted are certain angle to give a reasonable slope.  The 
agar in the bottles was left to harden at room temperature. 
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Muller-Hinton Broth (MHB) 
 
Muller-Hinton Broth (MHB) was agar weighing 38 g was dissolved in 400 ml of distilled 
water in an Erlenmeyer flask using a magnetic stirrer.  The solution was poured into 
universal bottles until half full, than autoclaved at 121
o
C for 20 minutes.  To make agar 
slants, the universal bottles were tilted are certain angle to give a reasonable slope.  The 
agar in the bottles was left to harden at room temperature. 
 
 
Yeast Peptone Dextrose Agar (YPDA) 
 
Yeast Peptone Dextrose Agar (YPDA) agar weighing 13.44 g was dissolved in 400 ml of 
distilled water in an Erlenmeyer flask using a magnetic stirrer.  The solution was poured 
into universal bottles until half full, than autoclaved at 121
o
C for 20 minutes.  To make agar 
slants, the universal bottles were tilted are certain angle to give a reasonable slope.  The 
agar in the bottles was left to harden at room temperature. 
 
 
Sabouraud dextrose agar (SDA) 
 
Sabouraud dextrose agar (SDA) agar weighing 65 g was dissolved in 400 ml of distilled 
water in an Erlenmeyer flask using a magnetic stirrer.  The solution was poured into 
universal bottles until half full, than autoclaved at 121
o
C for 20 minutes.  To make agar 
slants, the universal bottles were tilted are certain angle to give a reasonable slope.  The 
agar in the bottles was left to harden at room temperature. 
 
 
Preparation of Glucose-Yeast-Malt-Peptone (GYMP) agar 
 
A 500 ml Erlenmeyer flask was filled with 0.4 g MgSO4.7H2O, 0.4g NH4Cl g KH2PO4, 0.4 
g K2HPO4, 6.0 g glucose3.2 g peptone, 3.2 g malt extract and 3.2 g yeast extract and 70.0 g 
bacteriological agar.  The contents were dissolved in 400 ml of distilled water using a 
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magnetic stirrer.  The flask was covered with non-absorbent cotton plugs and aluminium 
foil, then autoclaved at 121
o
C for 20 minutes.  The sterilized medium was left to cool, then 
poured into Petri dishes aseptically and allowed them to harden.   
 
 
Cell Culture 
 
Basic Medium 199 
 
One sachet of medium 199 (Flow lab, Australia) that containing Earle‘s salt with L-
Glutamine and HEPES (N-2-Hydroxylethyl-Piperazine-N-2-Ethane-sulfonoc Acid, Sigma, 
USA) without sodium bicarbonate (Flow Lab).  Was made up to 1 litre with distilled water.  
Two grams of sodium bicarbonate (NaHCO3, Merck, Germany) was added to the medium.  
The medium was filter sterilized using a 0.22 µm filter membrane. (Schleicher & Schuell) 
and stored at 4
o
C for up to 4 months. 
 
RPMI 1640 Medium 
 
One bottle of RPMI 1640 powder with Earle‘s salts and L-glutamine (Flow lab) was made 
up to one litre with sterile distilled water.  Two grammes of sodium bicarbonate (Merck) 
and 0.5206 g of N – 2 – hydroxyrthyl – piperazine – N‘ – 2 – ethane – sulfonic acid 
(HEPES, Sigma) were added. The medium was stirred and pH was adjusted to pH 7.4.  The 
medium was filter sterilized using 0.2 µm cellulose filter membrane (Schleicher & Schuell) 
and stored at 4
o
C up to a shelf life of 2 months. 
 
 
 
10% Supllemented RPMI medium  and 199 medium  
 
100 ml of 10% supplemented RPMI 1640 medium and medium 199 was prepared by 
mixing 90 ml of basic medium, 10 ml of heat inactivated foetal bovine serum (FBS was 
heated at 56
o
C for 30 minutes, Flowlab), 2 ml of penicillin/streptomycin (PAA Laboratory 
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HmbG) and 1 ml of amphostat B (Flowlab) in a beaker. The pH was adjusted according to 
the colour of the medium by adding hyrochloric acid (Systerm) or sodium hydroxide 
(Systerm). The desired ph 7.2 – 7.4 where the medium should appear as reddish orange.  
The medium was filter sterilized using 0.2 µm cellulose filter membrane and stored at
 
4
o
C 
up to two weeks.  
 
 
20% Supplemented RPMI 1640 Medium and Medium 199 
 
50 ml of 20% supplemented RPMI 1640 medium and medium 199 was prepared by mixing 
45 ml of 10% supplemented medium and 5 ml of heat inactivated foetal bovine serum in a 
beaker.  The medium was filter sterilized using 0.2 µm cellulose filter membrane and stored 
at 4
o
C up to 2 weeks.  This 20% supplemented medium was used as revived cell.  
 
 
Freezing Medium 
 
The freezing medium consisted of 50% inactivated foetal bovine serum, 40% RPMI 1640 
medium and 10% dimethyl sulfoxide (DMSO, Sigma).  The solution was mixed well by 
using a 20 ml disposable syringe (Terumo) and filters membrane and kept 4
o
C. Freshly 
prepared freezing medium was used for cryopreservation of cells.  
 
 
Phosphate Buffer Saline (PBS) ph 7.2  
 
The phosphate buffer saline was prepared using 1.52 g of sodium phosphate anhydrous 
(Na2HPO4, Merck) and 8.5 g of sodium chloride (NaCl, BDH Lab Supplies), which were 
dissolved in 1 litre of sterile distilled water.  The solution was stirred and the pH was 
adjusted to pH 7.2.  the solution was then filtered into a sterile bottle using filter paper 
(Whatman 541).  The solution was autoclaved (P-Selecta) and kept at room temperature. 
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Phosphate Buffer Saline (PBS) pH 7.6 
 
The phosphate buffer saline was prepared using 1.5 g of potassium phosphate anhydrous 
(K2HPO4, BDH Lab Supplies, 0.2  g of potassium dihyrogen orthophosphate (KH2PO4, 
Merck) and 7.75 g of sodium chloride (NaCl, BDH Lab Supplies), which were dissolved in 
1 litre of sterile distilled water.  The solution was stirred and pH was adjusted to pH 7.6. 
The solution was then filtered using filter filter paper and kept at rom temperature. 
 
 
10% Dimethyl Sulfoxide (DMSO) 
 
The 10% DMSO solution was prepared by mixing DMSO (Sigma) with sterile distilled 
water in a ration of 1:9.  Freshly prepared 10% DMSO was used for the neutral red 
cytotoxic assay. 
 
 
0.4% Tryphan Blue 
 
0.4% Tryphan blue was prepared by dissolving 0.2g powdered tryphan blue (Sigma) in 50 
ml of sterile distilled water.  The solution was kept at room temperature. 
 
 
Neutral Red Stock Solution 
 
Neutral red stock solution was prepared by dissolving 0.04 g of neutral red (ICN 
Biomedicals Inc.) in 10 ml of sterile distilled water to provide a final concentration of 4 
mg/ml.  The stock solution was wrapped with aluminum foil and stored at 4
o
C. 
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Neutral Red – Medium 
The neutral red stock solution was further diluted with 10% RPMI 1640 medium to provide 
a final concentration of 50 µg/ml in a centrifuge tube.  The solution was wrapped with 
aluminum foil and kept at room temperature.  The solution was centrifuged twice at 1, 500 
rpm for 10 min to removed any precipitate of dye crystals.  
 
 
Washing Solution 
 
The washing solution consisted of 1 ml of formaldehyde (Sigma) and 1 g of calcium 
chloride (CaCl2, Sigma), which were dissolved in 100 ml distilled water and stored at  
4
o
C. 
 
 
Resorb Solution 
The resorb solution was prepared by adding 1 ml of glacial acetic (BDH Lab Supplies) with 
9 ml absolute ethanol (HmbG chemicals) and 50 ml absolute ethanol (HmbG chemicals) 
and 50 ml distilled water. The solution was store 4
o
C. 
 
 
3% Hydrogen Peroxide 
The 3% hydrogen peroxide was prepared by mixing 1 ml of 30% hydrogen peroxide (H2O2, 
BDH Lab Supplies) with 9 ml of distilled water.  The solution was wrapped with aluminum 
foil and kept at room temperature. 
 
 
Antioxidant Activity Assay 
 
Preparation of stock solution 
 
A stock solution of 20 mg/ml of each extract was prepared and wrapped in aluminium foil.  
The crude extracts were dissolved in methanol (Systerm). 
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APPENDIX B (EXPERIMENTAL DATA) 
 
Results    
 
Reaction kinetics of scavenging effect on 2,2-diphenyl-1-picrylhydrazyl (DPPH
.
) 
radical 
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Standard calibration curve for total phenolics contain obtained from gallic acid using 
Follin-Ciocalteau method. 
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Antimicrobial 
 
Gram positive bacteria                         
  
 
                                 Penicilliopsis sp. (KUM60280) against Staphylococcus aureus, Sa 
M: Methanol; D; Dichloromethane; S; Streptomycin; C: Chloromphenicol; K: Kanamycin; 
N:Nystatin 
 
 
 
 
                                                   Penicilliopsis sp. (KUM60280) against Bacillus subtilis, Bs 
M: Methanol; D; Dichloromethane; S; Streptomycin; C: Chloromphenicol; K: Kanamycin; 
N:Nystatin 
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Penicilliopsis sp. (KUM60280) against Bacillus cereus, Bc 
M: Methanol; D; Dichloromethane; S; Streptomycin; C: Chloromphenicol; K: Kanamycin; 
N:Nystatin 
 
 
 
 
Oral Bacteria 
 
 
 
Penicilliopsis sp. (KUM60280) against Streptococcus mutan, Sm 
M: Methanol; D; Dichloromethane; S; Streptomycin; C: Chloromphenicol; K: Kanamycin; 
N:Nystatin 
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Penicilliopsis sp. (KUM60280) against Streptococcus mitis, Si 
M: Methanol; D; Dichloromethane; S; Streptomycin; C: Chloromphenicol; K: Kanamycin; 
N:Nystatin 
 
 
 
 
 
 
Penicilliopsis sp. (KUM60280) against Streptococcus sanguis, Ss 
M: Methanol; D; Dichloromethane; S; Streptomycin; C: Chloromphenicol; K: Kanamycin; 
N:Nystatin 
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Gram negative bacteria 
 
 
 
 
Penicilliopsis sp. (KUM60280) against Pseudomonas aeruginosa, Pa 
M: Methanol; D; Dichloromethane; S; Streptomycin; C: Chloromphenicol; K: Kanamycin; 
N:Nystatin 
 
 
 
 
 
Penicilliopsis sp. (KUM60280) against Pseudomonas vulgaria, Pv 
M: Methanol; D; Dichloromethane; S; Streptomycin; C: Chloromphenicol; K: Kanamycin; 
N:Nystatin 
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Penicilliopsis sp. (KUM60280) against Escherichia coli, Ec 
M: Methanol; D; Dichloromethane; S; Streptomycin; C: Chloromphenicol; K: Kanamycin; 
N:Nystatin 
 
 
 
 
Anti-fungal  
 
 
 
Penicilliopsis sp. (KUM60280) against Candida albican, Ca 
M: Methanol; D; Dichloromethane; S; Streptomycin; C: Chloromphenicol; K: Kanamycin; 
N:Nystatin 
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  Penicilliopsis sp. (KUM60280) against Candida parasilopsis, Cp 
M: Methanol; D; Dichloromethane; S; Streptomycin; C: Chloromphenicol; K:Kanamycin; 
N:Nystatin 
 
 
          
 
 
Penicilliopsis sp. (KUM60280) against Saccromyces pombe, Sp 
M: Methanol; D; Dichloromethane; S; Streptomycin; C: Chloromphenicol; K : Kanamycin; 
N:Nystatin 
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Appendix C: Statistic 
 
One-way ANOVA to compare decrease in absorbance values to determine time taken 
to reach steady state during scavenging of DPPH
.
  
 
Methanol 
25mg/ml 
 
-------------------------------------------------------------------------------- 
TIME           Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
   60                  3         0.157667                        X     
   45                  3         0.183667                        XX    
   30                  3         0.211333                        X    
   15                  3         0.264667                        X   
   2                    3         0.368                              X  
   1                    3         0.383667                        XX 
   0                    3         0.408                              X 
-------------------------------------------------------------------------------- 
Contrast                               Difference           +/-  Limits 
-------------------------------------------------------------------------------- 
0 - 1                                      0.0243333             0.0277497          
0 - 2                                     *0.04                      0.0277497          
0 - 15                                    *0.143333             0.0277497          
0 - 30                                    *0.196667             0.0277497          
0 - 45                                    *0.224333             0.0277497          
0 - 60                                    *0.250333             0.0277497          
1 - 2                                      0.0156667             0.0277497          
1 - 15                                    *0.119                   0.0277497          
1 - 30                                    *0.172333             0.0277497          
1 - 45                                    *0.2                       0.0277497          
1 - 60                                    *0.226                   0.0277497          
2 - 15                                    *0.103333             0.0277497          
2 - 30                                    *0.156667             0.0277497          
2 - 45                                    *0.184333             0.0277497          
2 - 60                                    *0.210333             0.0277497          
15 - 30                                   *0.0533333          0.0277497          
15 - 45                                   *0.081                  0.0277497          
15 - 60                                   *0.107                  0.0277497          
30 - 45                                    0.0276667           0.0277497          
30 - 60                                   *0.0536667          0.0277497          
45 - 60                                    0.026                   0.0277497          
-------------------------------------------------------------------------------- 
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30mg/ml 
-------------------------------------------------------------------------------- 
TIME           Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
   60                3         0.133333                        X       
   45                3         0.159                              X      
   30                3         0.184333                        X     
   15                3         0.237333                        X    
   2                  3         0.352                              X   
   1                  3         0.371667                        X  
   0                  3         0.407                              X 
-------------------------------------------------------------------------------- 
Contrast                                   Difference           +/-  Limits 
-------------------------------------------------------------------------------- 
0 - 1                                     *0.0353333             0.0191531          
0 - 2                                     *0.055                     0.0191531          
0 - 15                                    *0.169667              0.0191531          
0 - 30                                    *0.222667              0.0191531          
0 - 45                                    *0.248                    0.0191531          
0 - 60                                    *0.273667              0.0191531          
1 - 2                                     *0.0196667             0.0191531          
1 - 15                                    *0.134333              0.0191531          
1 - 30                                    *0.187333              0.0191531          
1 - 45                                    *0.212667              0.0191531          
1 - 60                                    *0.238333              0.0191531          
2 - 15                                    *0.114667              0.0191531          
2 - 30                                    *0.167667              0.0191531          
2 - 45                                    *0.193                    0.0191531          
2 - 60                                    *0.218667              0.0191531          
15 - 30                                   *0.053                   0.0191531          
15 - 45                                   *0.0783333           0.0191531          
15 - 60                                   *0.104                   0.0191531          
30 - 45                                   *0.0253333           0.0191531          
30 - 60                                   *0.051                   0.0191531          
45 - 60                                   *0.0256667           0.0191531          
-------------------------------------------------------------------------------- 
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40mg/ml 
 
-------------------------------------------------------------------------------- 
TIME           Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
   60                 3         0.0606667                    X     
   45                 3         0.0703333                    X     
   30                 3         0.121                            X     
   15                 3         0.159333                      X   
   2                   3         0.287                            X  
   1                   3         0.308                            X  
   0                   3         0.354                            X 
-------------------------------------------------------------------------------- 
Contrast                                   Difference           +/-  Limits 
-------------------------------------------------------------------------------- 
0 - 1                                     *0.046                     0.0236622          
0 - 2                                     *0.067                     0.0236622          
0 - 15                                    *0.194667              0.0236622          
0 - 30                                    *0.233                    0.0236622          
0 - 45                                    *0.283667              0.0236622          
0 - 60                                    *0.293333              0.0236622          
1 - 2                                         0.021                   0.0236622          
1 - 15                                    *0.148667              0.0236622          
1 - 30                                    *0.187                    0.0236622          
1 - 45                                    *0.237667              0.0236622          
1 - 60                                    *0.247333              0.0236622          
2 - 15                                    *0.127667              0.0236622          
2 - 30                                    *0.166                    0.0236622          
2 - 45                                    *0.216667              0.0236622          
2 - 60                                    *0.226333              0.0236622          
15 - 30                                   *0.0383333           0.0236622          
15 - 45                                   *0.089                   0.0236622          
15 - 60                                   *0.0986667           0.0236622          
30 - 45                                   *0.0506667           0.0236622          
30 - 60                                   *0.0603333           0.0236622          
45 - 60                                    0.00966667          0.0236622          
-------------------------------------------------------------------------------- 
 
 
 
 
 
 
 
 
 
 
 
126 
 
50mg/ml 
-------------------------------------------------------------------------------- 
TIME           Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
   60                    3         0.0626667                   X    
   45                    3         0.0653333                   X    
   30                    3         0.0663333                   X    
   15                    3         0.0726667                   X    
   2                      3         0.207                           X   
   1                      3         0.232                           X  
   0                      3         0.286333                     X 
-------------------------------------------------------------------------------- 
Contrast                                   Difference           +/-  Limits 
-------------------------------------------------------------------------------- 
0 - 1                                     *0.0543333            0.0112067          
0 - 2                                     *0.0793333            0.0112067          
0 - 15                                    *0.213667             0.0112067          
0 - 30                                    *0.22                     0.0112067          
0 - 45                                    *0.221                   0.0112067          
0 - 60                                    *0.223667             0.0112067          
1 - 2                                     *0.025                    0.0112067          
1 - 15                                    *0.159333             0.0112067          
1 - 30                                    *0.165667             0.0112067          
1 - 45                                    *0.166667             0.0112067          
1 - 60                                    *0.169333             0.0112067          
2 - 15                                    *0.134333             0.0112067          
2 - 30                                    *0.140667             0.0112067          
2 - 45                                    *0.141667             0.0112067          
2 - 60                                    *0.144333             0.0112067          
15 - 30                                    0.00633333         0.0112067          
15 - 45                                    0.00733333         0.0112067          
15 - 60                                    0.01                 0.0112067          
30 - 45                                    0.001                0.0112067          
30 - 60                                    0.00366667           0.0112067          
45 - 60                                    0.00266667           0.0112067          
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DCM 
 
10 mg/ml 
-------------------------------------------------------------------------------- 
Time           Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
   60                    3         0.228                           X     
   45                    3         0.341667                     X    
   30                    3         0.371667                     X   
   15                    3         0.393667                     X   
   2                      3         0.436333                     X  
   1                      3         0.455333                     XX 
   0                      3         0.465333                     X 
-------------------------------------------------------------------------------- 
Contrast                                   Difference           +/-  Limits 
-------------------------------------------------------------------------------- 
0 - 1                                      0.01                          0.0233547          
0 - 2                                     *0.029                       0.0233547          
0 - 15                                    *0.0716667              0.0233547          
0 - 30                                    *0.0936667              0.0233547          
0 - 45                                    *0.123667                0.0233547          
0 - 60                                    *0.237333                0.0233547          
1 - 2                                      0.019                        0.0233547          
1 - 15                                    *0.0616667              0.0233547          
1 - 30                                    *0.0836667              0.0233547          
1 - 45                                    *0.113667                0.0233547          
1 - 60                                    *0.227333                0.0233547          
2 - 15                                    *0.0426667              0.0233547          
2 - 30                                    *0.0646667              0.0233547          
2 - 45                                    *0.0946667              0.0233547          
2 - 60                                    *0.208333                0.0233547          
15 - 30                                    0.022                      0.0233547          
15 - 45                                   *0.052                     0.0233547          
15 - 60                                   *0.165667               0.0233547          
30 - 45                                   *0.03                       0.0233547          
30 - 60                                   *0.143667               0.0233547          
45 - 60                                   *0.113667               0.0233547          
-------------------------------------------------------------------------------- 
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30 mg/ml 
-------------------------------------------------------------------------------- 
Time           Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
   60             3         0.228                                  X     
   45             3         0.341667                            X    
   30             3         0.371667                            X   
   15             3         0.393667                            X   
   2               3         0.436333                            X  
   1              3         0.455333                             XX 
   0              3         0.465333                             X 
 
 
-------------------------------------------------------------------------------- 
Contrast                                   Difference           +/-  Limits 
-------------------------------------------------------------------------------- 
0 - 1                                      0.01                          0.0233547          
0 - 2                                     *0.029                       0.0233547          
0 - 15                                    *0.0716667              0.0233547          
0 - 30                                    *0.0936667              0.0233547          
0 - 45                                    *0.123667                0.0233547          
0 - 60                                    *0.237333                0.0233547          
1 - 2                                      0.019                        0.0233547          
1 - 15                                    *0.0616667              0.0233547          
1 - 30                                    *0.0836667              0.0233547          
1 - 45                                    *0.113667                0.0233547          
1 - 60                                    *0.227333                0.0233547          
2 - 15                                    *0.0426667              0.0233547          
2 - 30                                    *0.0646667              0.0233547          
2 - 45                                    *0.0946667              0.0233547          
2 - 60                                    *0.208333                0.0233547          
15 - 30                                    0.022                      0.0233547          
15 - 45                                   *0.052                     0.0233547          
15 - 60                                   *0.165667               0.0233547          
30 - 45                                   *0.03                       0.0233547          
30 - 60                                   *0.143667               0.0233547          
45 - 60                                   *0.113667               0.0233547          
-------------------------------------------------------------------------------- 
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50 mg/ml 
-------------------------------------------------------------------------------- 
Time           Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
   60             3         0.219667                           X      
   45             3         0.270333                           X     
   30             3         0.316667                           X    
   15             3         0.356                                 X   
   2              3         0.376333                            X  
   1              3         0.398                                  X 
   0              3         0.416667                            X 
-------------------------------------------------------------------------------- 
Contrast                                   Difference           +/-  Limits 
-------------------------------------------------------------------------------- 
0 - 1                                      0.0186667               0.0200727          
0 - 2                                     *0.0403333              0.0200727          
0 - 15                                    *0.0606667             0.0200727          
0 - 30                                    *0.1                         0.0200727          
0 - 45                                    *0.146333               0.0200727          
0 - 60                                    *0.197                     0.0200727          
1 - 2                                     *0.0216667              0.0200727          
1 - 15                                    *0.042                     0.0200727          
1 - 30                                    *0.0813333             0.0200727          
1 - 45                                    *0.127667               0.0200727          
1 - 60                                    *0.178333               0.0200727          
2 - 15                                    *0.0203333             0.0200727          
2 - 30                                    *0.0596667             0.0200727          
2 - 45                                    *0.106                     0.0200727          
2 - 60                                    *0.156667               0.0200727          
15 - 30                                   *0.0393333            0.0200727          
15 - 45                                   *0.0856667            0.0200727          
15 - 60                                   *0.136333              0.0200727          
30 - 45                                   *0.0463333            0.0200727          
30 - 60                                   *0.097                    0.0200727          
45 - 60                                   *0.0506667            0.0200727          
-------------------------------------------------------------------------------- 
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70 mg/ml 
-------------------------------------------------------------------------------- 
Time           Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
60             3         0.225                                         X     
45             3         0.289667                                   X    
30             3         0.320667                                   X   
15             3         0.353333                                   X  
2              3         0.374333                                    X 
1              3         0.383                                          X 
0              3         0.394667                                    X 
 
 
-------------------------------------------------------------------------------- 
Contrast                                   Difference           +/-  Limits 
-------------------------------------------------------------------------------- 
0 - 1                                      0.0116667              0.0204618          
0 - 2                                      0.0203333              0.0204618          
0 - 15                                    *0.0413333            0.0204618          
0 - 30                                    *0.074                    0.0204618          
0 - 45                                    *0.105                    0.0204618          
0 - 60                                    *0.169667              0.0204618          
1 - 2                                      0.00866667            0.0204618          
1 - 15                                    *0.0296667            0.0204618          
1 - 30                                    *0.0623333            0.0204618          
1 - 45                                    *0.0933333            0.0204618          
1 - 60                                    *0.158                    0.0204618          
2 - 15                                    *0.021                    0.0204618          
2 - 30                                    *0.0536667            0.0204618          
2 - 45                                    *0.0846667            0.0204618          
2 - 60                                    *0.149333               0.0204618          
15 - 30                                   *0.0326667            0.0204618          
15 - 45                                   *0.0636667            0.0204618          
15 - 60                                   *0.128333              0.0204618          
30 - 45                                   *0.031                    0.0204618          
30 - 60                                   *0.0956667            0.0204618          
45 - 60                                   *0.0646667            0.0204618          
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100 mg/ml 
 
 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Time           Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
60             3         0.175667                                  X      
45             3         0.213333                                  X     
30             3         0.238333                                  X    
15             3         0.287                                        X   
2              3         0.321                                         X  
1              3         0.331333                                  XX 
0              3         0.345                                         X 
-------------------------------------------------------------------------------- 
Contrast                                   Difference           +/-  Limits 
-------------------------------------------------------------------------------- 
0 - 1                                      0.0136667               0.01869            
0 - 2                                     *0.024                      0.01869            
0 - 15                                    *0.058                     0.01869            
0 - 30                                    *0.106667               0.01869            
0 - 45                                    *0.131667               0.01869            
0 - 60                                    *0.169333               0.01869            
1 - 2                                      0.0103333               0.01869            
1 - 15                                    *0.0443333             0.01869            
1 - 30                                    *0.093                     0.01869            
1 - 45                                    *0.118                     0.01869            
1 - 60                                    *0.155667               0.01869            
2 - 15                                    *0.034                     0.01869            
2 - 30                                    *0.0826667             0.01869            
2 - 45                                    *0.107667               0.01869            
2 - 60                                    *0.145333               0.01869            
15 - 30                                   *0.0486667            0.01869            
15 - 45                                   *0.0736667            0.01869            
15 - 60                                   *0.111333              0.01869            
30 - 45                                   *0.025                    0.01869            
30 - 60                                   *0.0626667            0.01869            
45 - 60                                   *0.0376667            0.01869            
-------------------------------------------------------------------------------- 
 
 
 
 
 
 
 
